activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177454	CHEMBL685974	Inhibition of Fes kinase	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	81.0	CHEMBL5455	Homo sapiens	Activity	%	81.0
	177454	CHEMBL685974	Inhibition of Fes kinase	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	81.0	CHEMBL5455	Homo sapiens	Activity	%	81.0
	178767	CHEMBL685974	Inhibition of Fes kinase	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	79.0	CHEMBL5455	Homo sapiens	Activity	%	79.0
	182514	CHEMBL685974	Inhibition of Fes kinase	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	87.0	CHEMBL5455	Homo sapiens	Activity	%	87.0
	1727571	CHEMBL859760	Inhibition of human Fes at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC	Outside typical range	CHEMBL210833	=	Inhibition	%	-12.0	CHEMBL5455	Homo sapiens	Inhibition	%	-12.0
	1734194	CHEMBL862473	Residual activity at human Fes at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	90.0	CHEMBL5455	Homo sapiens	Activity	%	90.0
	1790067	CHEMBL855328	Percentage activity of human Fes in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	134.0	CHEMBL5455	Homo sapiens	Activity	%	134.0
	1815215	CHEMBL908527	Inhibition of Fes	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	25000.0	CHEMBL5455	Homo sapiens	IC50	nM	25000.0
	1815347	CHEMBL910180	Inhibition of Fes	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	910.0	CHEMBL5455	Homo sapiens	IC50	nM	910.0
	1898416	CHEMBL887690	Inhibition of FES	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL5455	Homo sapiens	Activity	uM	10.0
	1977700	CHEMBL897767	Inhibition of FES at 3 uM	B	CO/N=C/c1c(N)ncnc1N1CCN(C(=O)Nc2ccc(OC(C)C)cc2)CC1		CHEMBL269594	=	Inhibition	%	34.0	CHEMBL5455	Homo sapiens	Inhibition	%	34.0
	2015690	CHEMBL885495	Inhibition of Fes at 10 uM	B	NC[C@H]1CC[C@H](c2nc(-c3cccc(OCc4ccccc4)c3)c3c(N)nccn32)CC1		CHEMBL392284	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	Inhibition	%	50.0
	2025139	CHEMBL886966	Inhibition of human Fes at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	133.0	CHEMBL5455	Homo sapiens	Inhibition	%	133.0
	2025309	CHEMBL886966	Inhibition of human Fes at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	107.0	CHEMBL5455	Homo sapiens	Inhibition	%	107.0
	2025310	CHEMBL886966	Inhibition of human Fes at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	130.0	CHEMBL5455	Homo sapiens	Inhibition	%	130.0
	2025311	CHEMBL886966	Inhibition of human Fes at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	139.0	CHEMBL5455	Homo sapiens	Inhibition	%	139.0
	2050269	CHEMBL925567	Inhibition of FES at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	1.0	CHEMBL5455	Homo sapiens	Inhibition	%	1.0
	2081788	CHEMBL928811	Inhibition of FES at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL5455	Homo sapiens	Inhibition	%	20.0
	2132654	CHEMBL921278	Inhibition of FES	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	uM	10.0
	2147260	CHEMBL921850	Activity of human Fes kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	133.0	CHEMBL5455	Homo sapiens	Activity	%	133.0
	2206905	CHEMBL974016	Inhibition of Fes	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	IC50	nM	1.0	CHEMBL5455	Homo sapiens	IC50	nM	1.0
	2206956	CHEMBL974016	Inhibition of Fes	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL5455	Homo sapiens	EC50	uM	1.0
	2341439	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	24.0	CHEMBL5455	Homo sapiens	INH	%	24.0
	2341480	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	97.0	CHEMBL5455	Homo sapiens	INH	%	97.0
	2341521	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	6.0	CHEMBL5455	Homo sapiens	INH	%	6.0
	2341562	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	45.0	CHEMBL5455	Homo sapiens	INH	%	45.0
	2341603	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2341644	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	2341685	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	8.0	CHEMBL5455	Homo sapiens	INH	%	8.0
	2341726	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	5.0	CHEMBL5455	Homo sapiens	INH	%	5.0
	2341767	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	INH	%	4.0
	2341808	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	24.0	CHEMBL5455	Homo sapiens	INH	%	24.0
	2341849	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2341890	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	10.0	CHEMBL5455	Homo sapiens	INH	%	10.0
	2341931	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	18.0	CHEMBL5455	Homo sapiens	INH	%	18.0
	2341972	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	2342013	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	2342054	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	75.0	CHEMBL5455	Homo sapiens	INH	%	75.0
	2342095	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	11.0	CHEMBL5455	Homo sapiens	INH	%	11.0
	2342136	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	17.0	CHEMBL5455	Homo sapiens	INH	%	17.0
	2342177	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	20.0	CHEMBL5455	Homo sapiens	INH	%	20.0
	2342225	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	22.0	CHEMBL5455	Homo sapiens	INH	%	22.0
	2342263	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	15.0	CHEMBL5455	Homo sapiens	INH	%	15.0
	2342300	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	18.0	CHEMBL5455	Homo sapiens	INH	%	18.0
	2342341	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	22.0	CHEMBL5455	Homo sapiens	INH	%	22.0
	2342382	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	51.0	CHEMBL5455	Homo sapiens	INH	%	51.0
	2342423	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	18.0	CHEMBL5455	Homo sapiens	INH	%	18.0
	2342464	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	8.0	CHEMBL5455	Homo sapiens	INH	%	8.0
	2342505	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	INH	%	4.0
	2342546	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	18.0	CHEMBL5455	Homo sapiens	INH	%	18.0
	2342637	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2342638	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2342639	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2342640	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2342641	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	2342642	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	16.0	CHEMBL5455	Homo sapiens	INH	%	16.0
	2342643	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	2342644	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	2342645	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	2342646	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	23.0	CHEMBL5455	Homo sapiens	INH	%	23.0
	2342647	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	9.0	CHEMBL5455	Homo sapiens	INH	%	9.0
	2342648	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	2.0	CHEMBL5455	Homo sapiens	INH	%	2.0
	2342649	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	2.0	CHEMBL5455	Homo sapiens	INH	%	2.0
	2342650	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	2.0	CHEMBL5455	Homo sapiens	INH	%	2.0
	2342651	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	2.0	CHEMBL5455	Homo sapiens	INH	%	2.0
	2342652	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	9.0	CHEMBL5455	Homo sapiens	INH	%	9.0
	2342653	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	INH	%	4.0
	2342654	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	INH	%	4.0
	2342655	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	5.0	CHEMBL5455	Homo sapiens	INH	%	5.0
	2342656	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	5.0	CHEMBL5455	Homo sapiens	INH	%	5.0
	2342657	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	2342658	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	2342659	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	2342660	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	8.0	CHEMBL5455	Homo sapiens	INH	%	8.0
	2342661	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	20.0	CHEMBL5455	Homo sapiens	INH	%	20.0
	2342662	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	8.0	CHEMBL5455	Homo sapiens	INH	%	8.0
	2342663	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	1.0	CHEMBL5455	Homo sapiens	INH	%	1.0
	2342664	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	90.0	CHEMBL5455	Homo sapiens	INH	%	90.0
	2342665	CHEMBL953400	Inhibition of FES at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	6.0	CHEMBL5455	Homo sapiens	INH	%	6.0
	2393757	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2393758	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2393759	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](C)CC/C=C/2		CHEMBL454394	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2393760	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCCC(=O)[C@@H](C)CC/C=C/2		CHEMBL453389	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2393761	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc(O)c2c(c1)/C=C/CC[C@H](C)C(=O)CCC[C@H](C)OC2=O		CHEMBL510836	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2393762	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL454173	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2393763	CHEMBL1004488	Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)[C@@H](C)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL453375	<	Tm	degrees C	2.0	CHEMBL5455	Homo sapiens	Tm	degrees C	2.0
	2449119	CHEMBL985572	Inhibition of FES	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	706.0	CHEMBL5455	Homo sapiens	IC50	nM	706.0
	2470218	CHEMBL983620	Inhibition of FES at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5455	Homo sapiens	INH	%	10.0
Not Evaluated	2476619	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2476822	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5455	Homo sapiens	Activity		
	2477879	CHEMBL988912	Binding affinity to human FES	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Kd	nM	149.0	CHEMBL5455	Homo sapiens	Kd	nM	149.0
Not Evaluated	2478661	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2478864	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2479719	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5455	Homo sapiens	Activity		
Active	2480718	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL5455	Homo sapiens	Activity		
	2506947	CHEMBL942613	Inhibition of Fes at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	2506948	CHEMBL942613	Inhibition of Fes at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
Not Evaluated	2577340	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2577543	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5455	Homo sapiens	Activity		
	2593545	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	31.9	CHEMBL5455	Homo sapiens	Activity	%	31.9
	2593748	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	3.3	CHEMBL5455	Homo sapiens	Activity	%	3.3
	2594014	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	5.7	CHEMBL5455	Homo sapiens	Activity	%	5.7
Not Evaluated	2594957	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2595160	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2595226	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5455	Homo sapiens	Activity		
	2596357	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	23.2	CHEMBL5455	Homo sapiens	Activity	%	23.2
Not Evaluated	2597626	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5455	Homo sapiens	Activity		
Not Evaluated	2597829	CHEMBL1035883	Binding affinity to human FES at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5455	Homo sapiens	Activity		
	2721605	CHEMBL1057434	Inhibition of Fes at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	2907073	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907074	CHEMBL1061072	Binding constant for FES kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907075	CHEMBL1061072	Binding constant for FES kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	360.0	CHEMBL5455	Homo sapiens	Kd	nM	360.0
	2907076	CHEMBL1061072	Binding constant for FES kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907077	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907078	CHEMBL1061072	Binding constant for FES kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907079	CHEMBL1061072	Binding constant for FES kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907080	CHEMBL1061072	Binding constant for FES kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907081	CHEMBL1061072	Binding constant for FES kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907082	CHEMBL1061072	Binding constant for FES kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907083	CHEMBL1061072	Binding constant for FES kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907084	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907085	CHEMBL1061072	Binding constant for FES kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	5700.0	CHEMBL5455	Homo sapiens	Kd	nM	5700.0
	2907086	CHEMBL1061072	Binding constant for FES kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907087	CHEMBL1061072	Binding constant for FES kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907088	CHEMBL1061072	Binding constant for FES kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907089	CHEMBL1061072	Binding constant for FES kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907090	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907091	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907092	CHEMBL1061072	Binding constant for FES kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907093	CHEMBL1061072	Binding constant for FES kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907094	CHEMBL1061072	Binding constant for FES kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907095	CHEMBL1061072	Binding constant for FES kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907096	CHEMBL1061072	Binding constant for FES kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907097	CHEMBL1061072	Binding constant for FES kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907098	CHEMBL1061072	Binding constant for FES kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907099	CHEMBL1061072	Binding constant for FES kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907100	CHEMBL1061072	Binding constant for FES kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907101	CHEMBL1061072	Binding constant for FES kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907102	CHEMBL1061072	Binding constant for FES kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907103	CHEMBL1061072	Binding constant for FES kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907104	CHEMBL1061072	Binding constant for FES kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907105	CHEMBL1061072	Binding constant for FES kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	23.0	CHEMBL5455	Homo sapiens	Kd	nM	23.0
	2907106	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907107	CHEMBL1061072	Binding constant for FES kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	960.0	CHEMBL5455	Homo sapiens	Kd	nM	960.0
	2907108	CHEMBL1061072	Binding constant for FES kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907109	CHEMBL1061072	Binding constant for FES kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2907110	CHEMBL1061072	Binding constant for FES kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	2921339	CHEMBL1053726	Inhibition of FES assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	3052607	CHEMBL1037583	Residual activity of FES at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	112.0	CHEMBL5455	Homo sapiens	Residual activity	%	112.0
	3053916	CHEMBL1045126	Residual activity of FES at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	112.0	CHEMBL5455	Homo sapiens	Residual activity	%	112.0
	3054168	CHEMBL1040636	Residual activity of FES at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	102.0	CHEMBL5455	Homo sapiens	Residual activity	%	102.0
	3055455	CHEMBL1037583	Residual activity of FES at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	105.0	CHEMBL5455	Homo sapiens	Residual activity	%	105.0
	3055707	CHEMBL1045126	Residual activity of FES at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	153.0	CHEMBL5455	Homo sapiens	Residual activity	%	153.0
	3057012	CHEMBL1040636	Residual activity of FES at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	107.0	CHEMBL5455	Homo sapiens	Residual activity	%	107.0
	3058332	CHEMBL1037583	Residual activity of FES at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	123.0	CHEMBL5455	Homo sapiens	Residual activity	%	123.0
	3058584	CHEMBL1045126	Residual activity of FES at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	208.0	CHEMBL5455	Homo sapiens	Residual activity	%	208.0
	3072930	CHEMBL1040636	Residual activity of FES at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	101.0	CHEMBL5455	Homo sapiens	Residual activity	%	101.0
	3213809	CHEMBL1108396	Inhibition of FES at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL5455	Homo sapiens	INH	%	1.0
	3224818	CHEMBL1099655	Inhibition of FES at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3225068	CHEMBL1099655	Inhibition of FES at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3331940	CHEMBL1169230	Inhibition of FES at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3333355	CHEMBL1169230	Inhibition of FES at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3334760	CHEMBL1169230	Inhibition of FES at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3336180	CHEMBL1169230	Inhibition of FES at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3337527	CHEMBL1169230	Inhibition of FES at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3337777	CHEMBL1169230	Inhibition of FES at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3339111	CHEMBL1169230	Inhibition of FES at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3340413	CHEMBL1169230	Inhibition of FES at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3340708	CHEMBL1169230	Inhibition of FES at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3342124	CHEMBL1169230	Inhibition of FES at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	3358575	CHEMBL1174420	Inhibition of FES at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.75	CHEMBL5455	Homo sapiens	INH	%	0.75
	3359017	CHEMBL1174420	Inhibition of FES at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.1	CHEMBL5455	Homo sapiens	INH	%	0.1
	3400015	CHEMBL1217212	Inhibition of human Fes at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	98.0	CHEMBL5455	Homo sapiens	INH	%	98.0
	3443395	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	24.0	CHEMBL5455	Homo sapiens	INH	%	24.0
	3443612	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	37.0	CHEMBL5455	Homo sapiens	INH	%	37.0
	3444767	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	22.0	CHEMBL5455	Homo sapiens	INH	%	22.0
	3445115	CHEMBL1244837	Binding affinity to FES	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	370.0	CHEMBL5455	Homo sapiens	Kd	nM	370.0
	3445391	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	19.0	CHEMBL5455	Homo sapiens	INH	%	19.0
	3445608	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	19.0	CHEMBL5455	Homo sapiens	INH	%	19.0
	3445817	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	3446007	CHEMBL1244428	Inhibition of FES at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	20.0	CHEMBL5455	Homo sapiens	INH	%	20.0
	3446245	CHEMBL1244585	Inhibition of FES	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	358.0	CHEMBL5455	Homo sapiens	IC50	nM	358.0
	3446271	CHEMBL1244597	Inhibition of FES at 10 mM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	83.0	CHEMBL5455	Homo sapiens	INH	%	83.0
	3448000	CHEMBL1249772	Inhibition of human Fes activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	3448076	CHEMBL1249772	Inhibition of human Fes activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	62.0	CHEMBL5455	Homo sapiens	INH	%	62.0
	3448433	CHEMBL1244837	Binding affinity to FES	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	3448755	CHEMBL1244837	Binding affinity to FES	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	3449431	CHEMBL1244837	Binding affinity to FES	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	960.0	CHEMBL5455	Homo sapiens	Kd	nM	960.0
	3449668	CHEMBL1244837	Binding affinity to FES	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	3450081	CHEMBL1244837	Binding affinity to FES	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	3451001	CHEMBL1244837	Binding affinity to FES	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	uM	10.0
	3463228	CHEMBL1252416	Inhibition of FES at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	40.0	CHEMBL5455	Homo sapiens	INH	%	40.0
	3463447	CHEMBL1252416	Inhibition of FES at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	16.0	CHEMBL5455	Homo sapiens	INH	%	16.0
	3463991	CHEMBL1252416	Inhibition of FES at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	37.0	CHEMBL5455	Homo sapiens	INH	%	37.0
	3556516	CHEMBL1285582	Inhibition of FES at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	21.0	CHEMBL5455	Homo sapiens	INH	%	21.0
	5120297	CHEMBL1645961	Inhibition of human Fes at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	97.0	CHEMBL5455	Homo sapiens	INH	%	97.0
	5122904	CHEMBL1647693	Inhibition of FES at 10 uM	B	Nc1nccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1643368	>	Inhibition	%	80.0	CHEMBL5455	Homo sapiens	INH	%	80.0
	5243704	CHEMBL1685667	Inhibition of Fes at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	28.0	CHEMBL5455	Homo sapiens	INH	%	28.0
	5243812	CHEMBL1685916	Inhibition of Fes at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	1.0	CHEMBL5455	Homo sapiens	INH	%	1.0
	5243925	CHEMBL1685667	Inhibition of Fes at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	5244033	CHEMBL1685916	Inhibition of Fes at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	5244906	CHEMBL1685667	Inhibition of Fes at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	48.0	CHEMBL5455	Homo sapiens	INH	%	48.0
	5245014	CHEMBL1685916	Inhibition of Fes at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	6.0	CHEMBL5455	Homo sapiens	INH	%	6.0
	5245165	CHEMBL1685667	Inhibition of Fes at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	19.0	CHEMBL5455	Homo sapiens	INH	%	19.0
	5245995	CHEMBL1685916	Inhibition of Fes at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	6167560	CHEMBL1769033	Binding affinity to human Fes assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	6167576	CHEMBL1769050	Binding affinity to human Fes assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	78.0	CHEMBL5455	Homo sapiens	Activity	%	78.0
	6167640	CHEMBL1768906	Inhibition of FES	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	Ki	uM	1.0
	6325312	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	20.0	CHEMBL5455	Homo sapiens	INH	%	20.0
	6325341	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	6325373	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	9.0	CHEMBL5455	Homo sapiens	INH	%	9.0
	6325405	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	1.0	CHEMBL5455	Homo sapiens	INH	%	1.0
	6325437	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	100.0	CHEMBL5455	Homo sapiens	INH	%	100.0
	6325466	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	11.0	CHEMBL5455	Homo sapiens	INH	%	11.0
	6325496	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	12.0	CHEMBL5455	Homo sapiens	INH	%	12.0
	6325524	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	14.0	CHEMBL5455	Homo sapiens	INH	%	14.0
	6325867	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	68.0	CHEMBL5455	Homo sapiens	INH	%	68.0
	6325897	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	70.0	CHEMBL5455	Homo sapiens	INH	%	70.0
	6325927	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	6325956	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	INH	%	3.0
	6325985	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	6326014	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	6.0	CHEMBL5455	Homo sapiens	INH	%	6.0
	6326043	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	13.0	CHEMBL5455	Homo sapiens	INH	%	13.0
	6326073	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	1.0	CHEMBL5455	Homo sapiens	INH	%	1.0
	6326101	CHEMBL1819988	Inhibition of FES expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 400 uM by fluorescence polarization assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	9.0	CHEMBL5455	Homo sapiens	INH	%	9.0
	6341059	CHEMBL1828228	Activity of FES kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	6375424	CHEMBL1840256	Inhibition of FES at 1 uM by radiometric assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCNC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC[C@]3(C)CC[C@]21C		CHEMBL1836927	=	Inhibition	%	59.0	CHEMBL5455	Homo sapiens	INH	%	59.0
	6385803	CHEMBL1838328	Inhibition of human FES in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	6385804	CHEMBL1838328	Inhibition of human FES in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	6385805	CHEMBL1838328	Inhibition of human FES in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	6385806	CHEMBL1838328	Inhibition of human FES in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	6385807	CHEMBL1838328	Inhibition of human FES in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	7567247	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7567706	CHEMBL1908549	Binding constant for FES kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7568177	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7568635	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7569220	CHEMBL1908549	Binding constant for FES kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7569680	CHEMBL1908549	Binding constant for FES kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	450.0	CHEMBL5455	Homo sapiens	Kd	nM	450.0
	7570152	CHEMBL1908549	Binding constant for FES kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7570173	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7570600	CHEMBL1908549	Binding constant for FES kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	960.0	CHEMBL5455	Homo sapiens	Kd	nM	960.0
	7571196	CHEMBL1908549	Binding constant for FES kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1900.0	CHEMBL5455	Homo sapiens	Kd	nM	1900.0
	7571653	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7572150	CHEMBL1908549	Binding constant for FES kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7572566	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	4.8	CHEMBL5455	Homo sapiens	Kd	nM	4.8
	7573177	CHEMBL1908549	Binding constant for FES kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1200.0	CHEMBL5455	Homo sapiens	Kd	nM	1200.0
	7573668	CHEMBL1908549	Binding constant for FES kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1100.0	CHEMBL5455	Homo sapiens	Kd	nM	1100.0
	7574137	CHEMBL1908549	Binding constant for FES kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7574545	CHEMBL1908549	Binding constant for FES kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7575174	CHEMBL1908549	Binding constant for FES kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7575645	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7576110	CHEMBL1908549	Binding constant for FES kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	3600.0	CHEMBL5455	Homo sapiens	Kd	nM	3600.0
	7576518	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	530.0	CHEMBL5455	Homo sapiens	Kd	nM	530.0
	7576687	CHEMBL1908549	Binding constant for FES kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7577146	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	110.0	CHEMBL5455	Homo sapiens	Kd	nM	110.0
	7577624	CHEMBL1908549	Binding constant for FES kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	750.0	CHEMBL5455	Homo sapiens	Kd	nM	750.0
	7578094	CHEMBL1908549	Binding constant for FES kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7578499	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7578695	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7579069	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7579519	CHEMBL1908549	Binding constant for FES kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7579993	CHEMBL1908549	Binding constant for FES kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7580462	CHEMBL1908549	Binding constant for FES kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7580865	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	7400.0	CHEMBL5455	Homo sapiens	Kd	nM	7400.0
	7581053	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7581438	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7581883	CHEMBL1908549	Binding constant for FES kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7582354	CHEMBL1908549	Binding constant for FES kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7582818	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	200.0	CHEMBL5455	Homo sapiens	Kd	nM	200.0
	7583399	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7583796	CHEMBL1908549	Binding constant for FES kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7584241	CHEMBL1908549	Binding constant for FES kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7584712	CHEMBL1908549	Binding constant for FES kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7585136	CHEMBL1908549	Binding constant for FES kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7585729	CHEMBL1908549	Binding constant for FES kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7586137	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7586583	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7587066	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7587690	CHEMBL1908549	Binding constant for FES kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7588109	CHEMBL1908549	Binding constant for FES kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	370.0	CHEMBL5455	Homo sapiens	Kd	nM	370.0
	7588591	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7589042	CHEMBL1908549	Binding constant for FES kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7589655	CHEMBL1908549	Binding constant for FES kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7590079	CHEMBL1908549	Binding constant for FES kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7590104	CHEMBL1908549	Binding constant for FES kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	52.0	CHEMBL5455	Homo sapiens	Kd	nM	52.0
	7590578	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7591029	CHEMBL1908549	Binding constant for FES kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7592080	CHEMBL1908549	Binding constant for FES kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7592553	CHEMBL1908549	Binding constant for FES kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7593006	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	330.0	CHEMBL5455	Homo sapiens	Kd	nM	330.0
	7593153	CHEMBL1908549	Binding constant for FES kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	360.0	CHEMBL5455	Homo sapiens	Kd	nM	360.0
	7593588	CHEMBL1908549	Binding constant for FES kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7594060	CHEMBL1908549	Binding constant for FES kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7594533	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7594985	CHEMBL1908549	Binding constant for FES kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7595121	CHEMBL1908549	Binding constant for FES kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7595565	CHEMBL1908549	Binding constant for FES kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7596039	CHEMBL1908549	Binding constant for FES kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7596510	CHEMBL1908549	Binding constant for FES kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1400.0	CHEMBL5455	Homo sapiens	Kd	nM	1400.0
	7596957	CHEMBL1908549	Binding constant for FES kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	23.0	CHEMBL5455	Homo sapiens	Kd	nM	23.0
	7597093	CHEMBL1908549	Binding constant for FES kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7597546	CHEMBL1908549	Binding constant for FES kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5455	Homo sapiens	Kd	nM	10000.0
	7598019	CHEMBL1908549	Binding constant for FES kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	590.0	CHEMBL5455	Homo sapiens	Kd	nM	590.0
	7598489	CHEMBL1908549	Binding constant for FES kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	680.0	CHEMBL5455	Homo sapiens	Kd	nM	680.0
	7922700	CHEMBL1919017	Inhibition of human recombinant FES at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	16.0	CHEMBL5455	Homo sapiens	INH	%	16.0
	7959763	CHEMBL1932856	Inhibition of FES	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL5455	Homo sapiens	IC50	uM	30.0
	7959764	CHEMBL1932856	Inhibition of FES	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL5455	Homo sapiens	IC50	uM	30.0
	8004388	CHEMBL1943593	Inhibition of human FES in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	8004389	CHEMBL1943593	Inhibition of human FES in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	8004390	CHEMBL1943593	Inhibition of human FES in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	8004391	CHEMBL1943593	Inhibition of human FES in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5455	Homo sapiens	INH	%	35.0
	8012907	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945557	=	Delta Tm	degrees C	0.7	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.7
	8012932	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCN(C(=O)OC(C)(C)C)CC1)NC2=O		CHEMBL1945558	=	Delta Tm	degrees C	0.4	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.4
	8012956	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	4.0	CHEMBL5455	Homo sapiens	deltaTm	degrees C	4.0
	8012980	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	N#CC1c2c([nH]c3c(Cl)c(Cl)ccc23)C(=O)NC12CCCCC2		CHEMBL1945560	=	Delta Tm	degrees C	-0.4	CHEMBL5455	Homo sapiens	deltaTm	degrees C	-0.4
	8013004	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O		CHEMBL1945561	=	Delta Tm	degrees C	0.3	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.3
	8013029	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C		CHEMBL1945562	=	Delta Tm	degrees C	0.4	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.4
	8018765	CHEMBL1948825	Inhibition of Fes assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	89.0	CHEMBL5455	Homo sapiens	Activity	%	89.0
	8018766	CHEMBL1948825	Inhibition of Fes assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	81.0	CHEMBL5455	Homo sapiens	Activity	%	81.0
	8018767	CHEMBL1948825	Inhibition of Fes assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	88.0	CHEMBL5455	Homo sapiens	Activity	%	88.0
	8026921	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21		CHEMBL474872	=	Delta Tm	degrees C	0.1	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.1
	8027533	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21		CHEMBL1945336	=	Delta Tm	degrees C	0.4	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.4
	8027558	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O		CHEMBL1945337	=	Delta Tm	degrees C	-0.3	CHEMBL5455	Homo sapiens	deltaTm	degrees C	-0.3
	8027583	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N		CHEMBL1945338	=	Delta Tm	degrees C	-0.2	CHEMBL5455	Homo sapiens	deltaTm	degrees C	-0.2
	8027608	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N		CHEMBL1945339	=	Delta Tm	degrees C	0.0	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.0
	8027633	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O		CHEMBL1945340	=	Delta Tm	degrees C	0.0	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.0
	8027669	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O		CHEMBL1945554	=	Delta Tm	degrees C	0.0	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.0
	8027694	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O		CHEMBL1945335	=	Delta Tm	degrees C	0.0	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.0
	8027719	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cn[nH]c(=O)c21		CHEMBL1945555	=	Delta Tm	degrees C	0.2	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.2
	8027744	CHEMBL1947278	Binding affinity to FES assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556	=	Delta Tm	degrees C	0.5	CHEMBL5455	Homo sapiens	deltaTm	degrees C	0.5
	8047116	CHEMBL1958857	Inhibition of FES at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	8061554	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.75	CHEMBL5455	Homo sapiens	Inhibition	%	-3.75
	8061661	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.34	CHEMBL5455	Homo sapiens	Inhibition	%	2.34
	8061885	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.11	CHEMBL5455	Homo sapiens	Inhibition	%	3.11
	8062076	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.69	CHEMBL5455	Homo sapiens	Inhibition	%	1.69
	8062416	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.6	CHEMBL5455	Homo sapiens	Inhibition	%	2.6
	8062578	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.01	CHEMBL5455	Homo sapiens	Inhibition	%	2.01
	8062900	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.98	CHEMBL5455	Homo sapiens	Inhibition	%	1.98
	8063032	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.2	CHEMBL5455	Homo sapiens	Inhibition	%	0.2
	8063256	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.79	CHEMBL5455	Homo sapiens	Inhibition	%	1.79
	8063423	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.66	CHEMBL5455	Homo sapiens	Inhibition	%	0.66
	8063755	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.52	CHEMBL5455	Homo sapiens	Inhibition	%	1.52
	8063937	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.19	CHEMBL5455	Homo sapiens	Inhibition	%	2.19
	8064276	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.53	CHEMBL5455	Homo sapiens	Inhibition	%	3.53
	8064486	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.22	CHEMBL5455	Homo sapiens	Inhibition	%	-0.22
	8064848	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.6	CHEMBL5455	Homo sapiens	Inhibition	%	0.6
	8065014	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.82	CHEMBL5455	Homo sapiens	Inhibition	%	1.82
	8065354	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.16	CHEMBL5455	Homo sapiens	Inhibition	%	2.16
	8065529	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.96	CHEMBL5455	Homo sapiens	Inhibition	%	1.96
	8065753	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.62	CHEMBL5455	Homo sapiens	Inhibition	%	3.62
	8065868	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.77	CHEMBL5455	Homo sapiens	Inhibition	%	0.77
	8066078	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.12	CHEMBL5455	Homo sapiens	Inhibition	%	1.12
	8066302	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.14	CHEMBL5455	Homo sapiens	Inhibition	%	0.14
	8066438	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.66	CHEMBL5455	Homo sapiens	Inhibition	%	3.66
	8066604	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.69	CHEMBL5455	Homo sapiens	Inhibition	%	0.69
	8066828	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.62	CHEMBL5455	Homo sapiens	Inhibition	%	0.62
	8066952	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.77	CHEMBL5455	Homo sapiens	Inhibition	%	1.77
	8067351	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.47	CHEMBL5455	Homo sapiens	Inhibition	%	2.47
	8067472	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.31	CHEMBL5455	Homo sapiens	Inhibition	%	1.31
	8067906	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.26	CHEMBL5455	Homo sapiens	Inhibition	%	1.26
	8068041	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.66	CHEMBL5455	Homo sapiens	Inhibition	%	10.66
	8068429	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.93	CHEMBL5455	Homo sapiens	Inhibition	%	0.93
	8068554	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.25	CHEMBL5455	Homo sapiens	Inhibition	%	2.25
	8068778	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.56	CHEMBL5455	Homo sapiens	Inhibition	%	0.56
	8068952	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.5	CHEMBL5455	Homo sapiens	Inhibition	%	2.5
	8069077	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.57	CHEMBL5455	Homo sapiens	Inhibition	%	0.57
	8069301	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.96	CHEMBL5455	Homo sapiens	Inhibition	%	0.96
	8069372	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	53.2	CHEMBL5455	Homo sapiens	Inhibition	%	53.2
	8069596	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.73	CHEMBL5455	Homo sapiens	Inhibition	%	6.73
	8069757	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.79	CHEMBL5455	Homo sapiens	Inhibition	%	1.79
	8070107	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.22	CHEMBL5455	Homo sapiens	Inhibition	%	1.22
	8070279	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.73	CHEMBL5455	Homo sapiens	Inhibition	%	2.73
	8070628	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.8	CHEMBL5455	Homo sapiens	Inhibition	%	0.8
	8070926	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	40.23	CHEMBL5455	Homo sapiens	Inhibition	%	40.23
	8071083	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.93	CHEMBL5455	Homo sapiens	Inhibition	%	0.93
	8071433	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.45	CHEMBL5455	Homo sapiens	Inhibition	%	0.45
	8071606	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	Inhibition	%	3.0
	8071955	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.23	CHEMBL5455	Homo sapiens	Inhibition	%	1.23
	8072269	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.51	CHEMBL5455	Homo sapiens	Inhibition	%	-0.51
	8072426	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.42	CHEMBL5455	Homo sapiens	Inhibition	%	0.42
	8072650	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.46	CHEMBL5455	Homo sapiens	Inhibition	%	1.46
	8072775	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.18	CHEMBL5455	Homo sapiens	Inhibition	%	-0.18
	8072942	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.91	CHEMBL5455	Homo sapiens	Inhibition	%	2.91
	8073166	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.27	CHEMBL5455	Homo sapiens	Inhibition	%	3.27
	8073291	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.15	CHEMBL5455	Homo sapiens	Inhibition	%	0.15
	8073634	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.01	CHEMBL5455	Homo sapiens	Inhibition	%	-0.01
	8073867	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.56	CHEMBL5455	Homo sapiens	Inhibition	%	0.56
	8074243	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.32	CHEMBL5455	Homo sapiens	Inhibition	%	1.32
	8074373	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.2	CHEMBL5455	Homo sapiens	Inhibition	%	0.2
	8074754	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.68	CHEMBL5455	Homo sapiens	Inhibition	%	1.68
	8074881	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.99	CHEMBL5455	Homo sapiens	Inhibition	%	0.99
	8075105	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.44	CHEMBL5455	Homo sapiens	Inhibition	%	0.44
	8075216	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.85	CHEMBL5455	Homo sapiens	Inhibition	%	0.85
	8075453	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.26	CHEMBL5455	Homo sapiens	Inhibition	%	-1.26
	8075818	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.13	CHEMBL5455	Homo sapiens	Inhibition	%	2.13
	8075960	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.64	CHEMBL5455	Homo sapiens	Inhibition	%	0.64
	8076184	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.21	CHEMBL5455	Homo sapiens	Inhibition	%	-0.21
	8076332	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.12	CHEMBL5455	Homo sapiens	Inhibition	%	2.12
	8076690	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	10.01	CHEMBL5455	Homo sapiens	Inhibition	%	10.01
	8076792	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.1	CHEMBL5455	Homo sapiens	Inhibition	%	-0.1
	8077016	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.6	CHEMBL5455	Homo sapiens	Inhibition	%	-0.6
	8077039	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.58	CHEMBL5455	Homo sapiens	Inhibition	%	-0.58
	8077263	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.28	CHEMBL5455	Homo sapiens	Inhibition	%	-0.28
	8077391	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.52	CHEMBL5455	Homo sapiens	Inhibition	%	2.52
	8077766	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.25	CHEMBL5455	Homo sapiens	Inhibition	%	0.25
	8077909	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.6	CHEMBL5455	Homo sapiens	Inhibition	%	1.6
	8078272	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.61	CHEMBL5455	Homo sapiens	Inhibition	%	-3.61
	8078598	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.52	CHEMBL5455	Homo sapiens	Inhibition	%	0.52
	8078848	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	5.21	CHEMBL5455	Homo sapiens	Inhibition	%	5.21
	8078964	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.91	CHEMBL5455	Homo sapiens	Inhibition	%	0.91
	8079188	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.11	CHEMBL5455	Homo sapiens	Inhibition	%	2.11
	8079346	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.94	CHEMBL5455	Homo sapiens	Inhibition	%	-0.94
	8079488	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.71	CHEMBL5455	Homo sapiens	Inhibition	%	1.71
	8079712	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.91	CHEMBL5455	Homo sapiens	Inhibition	%	1.91
	8079851	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.97	CHEMBL5455	Homo sapiens	Inhibition	%	-0.97
	8080180	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.86	CHEMBL5455	Homo sapiens	Inhibition	%	0.86
	8080432	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.89	CHEMBL5455	Homo sapiens	Inhibition	%	-0.89
	8080771	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.67	CHEMBL5455	Homo sapiens	Inhibition	%	0.67
	8080935	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.05	CHEMBL5455	Homo sapiens	Inhibition	%	0.05
	8081294	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.4	CHEMBL5455	Homo sapiens	Inhibition	%	3.4
	8081438	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	62.54	CHEMBL5455	Homo sapiens	Inhibition	%	62.54
	8081765	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.55	CHEMBL5455	Homo sapiens	Inhibition	%	0.55
	8082017	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.27	CHEMBL5455	Homo sapiens	Inhibition	%	-0.27
	8082354	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.33	CHEMBL5455	Homo sapiens	Inhibition	%	1.33
	8082527	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.81	CHEMBL5455	Homo sapiens	Inhibition	%	-3.81
	8082874	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.48	CHEMBL5455	Homo sapiens	Inhibition	%	2.48
	8083030	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	80.53	CHEMBL5455	Homo sapiens	Inhibition	%	80.53
	8083254	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.9	CHEMBL5455	Homo sapiens	Inhibition	%	2.9
	8083353	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.14	CHEMBL5455	Homo sapiens	Inhibition	%	1.14
	8083607	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.28	CHEMBL5455	Homo sapiens	Inhibition	%	-2.28
	8083941	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.63	CHEMBL5455	Homo sapiens	Inhibition	%	2.63
	8084126	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.68	CHEMBL5455	Homo sapiens	Inhibition	%	-3.68
	8084350	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.15	CHEMBL5455	Homo sapiens	Inhibition	%	2.15
	8084468	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.75	CHEMBL5455	Homo sapiens	Inhibition	%	1.75
	8084853	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.18	CHEMBL5455	Homo sapiens	Inhibition	%	3.18
	8084951	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.9	CHEMBL5455	Homo sapiens	Inhibition	%	0.9
	8085175	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.23	CHEMBL5455	Homo sapiens	Inhibition	%	1.23
	8085207	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.92	CHEMBL5455	Homo sapiens	Inhibition	%	-1.92
	8085431	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.54	CHEMBL5455	Homo sapiens	Inhibition	%	-4.54
	8085539	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.33	CHEMBL5455	Homo sapiens	Inhibition	%	2.33
	8085952	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	6.75	CHEMBL5455	Homo sapiens	Inhibition	%	6.75
	8086067	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.58	CHEMBL5455	Homo sapiens	Inhibition	%	2.58
	8086291	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.25	CHEMBL5455	Homo sapiens	Inhibition	%	3.25
	8086453	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.73	CHEMBL5455	Homo sapiens	Inhibition	%	2.73
	8086776	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.83	CHEMBL5455	Homo sapiens	Inhibition	%	0.83
	8086987	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.89	CHEMBL5455	Homo sapiens	Inhibition	%	2.89
	8087145	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.9	CHEMBL5455	Homo sapiens	Inhibition	%	4.9
	8087369	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.63	CHEMBL5455	Homo sapiens	Inhibition	%	3.63
	8087483	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.48	CHEMBL5455	Homo sapiens	Inhibition	%	6.48
	8087845	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.42	CHEMBL5455	Homo sapiens	Inhibition	%	6.42
	8087987	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.22	CHEMBL5455	Homo sapiens	Inhibition	%	5.22
	8088211	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.85	CHEMBL5455	Homo sapiens	Inhibition	%	4.85
	8088359	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.07	CHEMBL5455	Homo sapiens	Inhibition	%	1.07
	8088711	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.85	CHEMBL5455	Homo sapiens	Inhibition	%	3.85
	8088804	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.26	CHEMBL5455	Homo sapiens	Inhibition	%	3.26
	8089028	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.57	CHEMBL5455	Homo sapiens	Inhibition	%	2.57
	8089156	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.64	CHEMBL5455	Homo sapiens	Inhibition	%	0.64
	8089528	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.31	CHEMBL5455	Homo sapiens	Inhibition	%	0.31
	8089648	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.48	CHEMBL5455	Homo sapiens	Inhibition	%	0.48
	8090052	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.62	CHEMBL5455	Homo sapiens	Inhibition	%	3.62
	8090217	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	14.02	CHEMBL5455	Homo sapiens	Inhibition	%	14.02
	8090608	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.16	CHEMBL5455	Homo sapiens	Inhibition	%	2.16
	8090747	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.59	CHEMBL5455	Homo sapiens	Inhibition	%	2.59
	8091176	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.93	CHEMBL5455	Homo sapiens	Inhibition	%	3.93
	8091313	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.62	CHEMBL5455	Homo sapiens	Inhibition	%	4.62
	8091692	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.61	CHEMBL5455	Homo sapiens	Inhibition	%	2.61
	8091808	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.25	CHEMBL5455	Homo sapiens	Inhibition	%	4.25
	8092032	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.85	CHEMBL5455	Homo sapiens	Inhibition	%	3.85
	8092169	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.02	CHEMBL5455	Homo sapiens	Inhibition	%	1.02
	8092544	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.73	CHEMBL5455	Homo sapiens	Inhibition	%	4.73
	8092692	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.64	CHEMBL5455	Homo sapiens	Inhibition	%	1.64
	8093045	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.83	CHEMBL5455	Homo sapiens	Inhibition	%	2.83
	8093357	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.95	CHEMBL5455	Homo sapiens	Inhibition	%	1.95
	8093497	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	8.02	CHEMBL5455	Homo sapiens	Inhibition	%	8.02
	8093860	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.29	CHEMBL5455	Homo sapiens	Inhibition	%	2.29
	8093980	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.35	CHEMBL5455	Homo sapiens	Inhibition	%	0.35
	8094204	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.33	CHEMBL5455	Homo sapiens	Inhibition	%	0.33
	8094384	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.75	CHEMBL5455	Homo sapiens	Inhibition	%	1.75
	8094559	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	59.17	CHEMBL5455	Homo sapiens	Inhibition	%	59.17
	8094783	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	39.85	CHEMBL5455	Homo sapiens	Inhibition	%	39.85
	8094939	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.03	CHEMBL5455	Homo sapiens	Inhibition	%	3.03
	8095079	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	4.7	CHEMBL5455	Homo sapiens	Inhibition	%	4.7
	8095303	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	21.84	CHEMBL5455	Homo sapiens	Inhibition	%	21.84
	8095506	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.54	CHEMBL5455	Homo sapiens	Inhibition	%	3.54
	8095647	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	16.51	CHEMBL5455	Homo sapiens	Inhibition	%	16.51
	8095871	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	57.31	CHEMBL5455	Homo sapiens	Inhibition	%	57.31
	8096019	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.06	CHEMBL5455	Homo sapiens	Inhibition	%	2.06
	8096360	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.02	CHEMBL5455	Homo sapiens	Inhibition	%	5.02
	8096499	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.03	CHEMBL5455	Homo sapiens	Inhibition	%	1.03
	8096879	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.27	CHEMBL5455	Homo sapiens	Inhibition	%	5.27
	8097026	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.45	CHEMBL5455	Homo sapiens	Inhibition	%	0.45
	8097250	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.01	CHEMBL5455	Homo sapiens	Inhibition	%	0.01
	8097337	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.59	CHEMBL5455	Homo sapiens	Inhibition	%	1.59
	8097557	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.62	CHEMBL5455	Homo sapiens	Inhibition	%	2.62
	8097707	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.53	CHEMBL5455	Homo sapiens	Inhibition	%	-0.53
	8097931	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.13	CHEMBL5455	Homo sapiens	Inhibition	%	5.13
	8098064	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.49	CHEMBL5455	Homo sapiens	Inhibition	%	-0.49
	8098408	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.11	CHEMBL5455	Homo sapiens	Inhibition	%	0.11
	8098588	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.63	CHEMBL5455	Homo sapiens	Inhibition	%	1.63
	8098997	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	81.72	CHEMBL5455	Homo sapiens	Inhibition	%	81.72
	8099141	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.79	CHEMBL5455	Homo sapiens	Inhibition	%	2.79
	8099507	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.84	CHEMBL5455	Homo sapiens	Inhibition	%	2.84
	8099701	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.05	CHEMBL5455	Homo sapiens	Inhibition	%	1.05
	8100072	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.32	CHEMBL5455	Homo sapiens	Inhibition	%	5.32
	8100218	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.0	CHEMBL5455	Homo sapiens	Inhibition	%	2.0
	8100558	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.61	CHEMBL5455	Homo sapiens	Inhibition	%	4.61
	8100698	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.31	CHEMBL5455	Homo sapiens	Inhibition	%	1.31
	8100922	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.62	CHEMBL5455	Homo sapiens	Inhibition	%	1.62
	8101082	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.97	CHEMBL5455	Homo sapiens	Inhibition	%	2.97
	8101448	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.68	CHEMBL5455	Homo sapiens	Inhibition	%	0.68
	8101633	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.74	CHEMBL5455	Homo sapiens	Inhibition	%	2.74
	8101886	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.82	CHEMBL5455	Homo sapiens	Inhibition	%	1.82
	8102265	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.33	CHEMBL5455	Homo sapiens	Inhibition	%	-2.33
	8102396	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.5	CHEMBL5455	Homo sapiens	Inhibition	%	0.5
	8102740	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.56	CHEMBL5455	Homo sapiens	Inhibition	%	0.56
	8102918	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.03	CHEMBL5455	Homo sapiens	Inhibition	%	2.03
	8103142	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.74	CHEMBL5455	Homo sapiens	Inhibition	%	1.74
	8103338	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.38	CHEMBL5455	Homo sapiens	Inhibition	%	4.38
	8103476	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.78	CHEMBL5455	Homo sapiens	Inhibition	%	3.78
	8103700	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.24	CHEMBL5455	Homo sapiens	Inhibition	%	1.24
	8103850	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.74	CHEMBL5455	Homo sapiens	Inhibition	%	2.74
	8104035	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.43	CHEMBL5455	Homo sapiens	Inhibition	%	1.43
	8104407	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	10.32	CHEMBL5455	Homo sapiens	Inhibition	%	10.32
	8104553	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.3	CHEMBL5455	Homo sapiens	Inhibition	%	0.3
	8104777	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.19	CHEMBL5455	Homo sapiens	Inhibition	%	0.19
	8104891	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.54	CHEMBL5455	Homo sapiens	Inhibition	%	4.54
	8105255	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.01	CHEMBL5455	Homo sapiens	Inhibition	%	-0.01
	8105421	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.83	CHEMBL5455	Homo sapiens	Inhibition	%	3.83
	8105783	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.45	CHEMBL5455	Homo sapiens	Inhibition	%	-1.45
	8106063	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.02	CHEMBL5455	Homo sapiens	Inhibition	%	3.02
	8106228	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.81	CHEMBL5455	Homo sapiens	Inhibition	%	2.81
	8106608	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	10.86	CHEMBL5455	Homo sapiens	Inhibition	%	10.86
	8106737	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.12	CHEMBL5455	Homo sapiens	Inhibition	%	0.12
	8106961	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.42	CHEMBL5455	Homo sapiens	Inhibition	%	-0.42
	8107082	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.81	CHEMBL5455	Homo sapiens	Inhibition	%	0.81
	8107478	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.76	CHEMBL5455	Homo sapiens	Inhibition	%	2.76
	8107679	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	7.88	CHEMBL5455	Homo sapiens	Inhibition	%	7.88
	8108038	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	7.67	CHEMBL5455	Homo sapiens	Inhibition	%	7.67
	8108196	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.32	CHEMBL5455	Homo sapiens	Inhibition	%	3.32
	8108371	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.11	CHEMBL5455	Homo sapiens	Inhibition	%	1.11
	8108595	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.57	CHEMBL5455	Homo sapiens	Inhibition	%	0.57
	8108742	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.96	CHEMBL5455	Homo sapiens	Inhibition	%	4.96
	8109108	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.82	CHEMBL5455	Homo sapiens	Inhibition	%	0.82
	8109222	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.03	CHEMBL5455	Homo sapiens	Inhibition	%	4.03
	8109446	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.78	CHEMBL5455	Homo sapiens	Inhibition	%	3.78
	8109576	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.02	CHEMBL5455	Homo sapiens	Inhibition	%	0.02
	8109747	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.48	CHEMBL5455	Homo sapiens	Inhibition	%	2.48
	8109971	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.52	CHEMBL5455	Homo sapiens	Inhibition	%	3.52
	8110103	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.89	CHEMBL5455	Homo sapiens	Inhibition	%	3.89
	8110382	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.58	CHEMBL5455	Homo sapiens	Inhibition	%	3.58
	8110548	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.87	CHEMBL5455	Homo sapiens	Inhibition	%	0.87
	8110772	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.2	CHEMBL5455	Homo sapiens	Inhibition	%	1.2
	8110930	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.95	CHEMBL5455	Homo sapiens	Inhibition	%	-1.95
	8111277	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.9	CHEMBL5455	Homo sapiens	Inhibition	%	0.9
	8111404	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.87	CHEMBL5455	Homo sapiens	Inhibition	%	2.87
	8111628	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.01	CHEMBL5455	Homo sapiens	Inhibition	%	2.01
	8111794	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.99	CHEMBL5455	Homo sapiens	Inhibition	%	1.99
	8111999	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.97	CHEMBL5455	Homo sapiens	Inhibition	%	1.97
	8112360	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.8	CHEMBL5455	Homo sapiens	Inhibition	%	0.8
	8112528	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.26	CHEMBL5455	Homo sapiens	Inhibition	%	3.26
	8112924	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.6	CHEMBL5455	Homo sapiens	Inhibition	%	1.6
	8113076	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.97	CHEMBL5455	Homo sapiens	Inhibition	%	7.97
	8113436	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.19	CHEMBL5455	Homo sapiens	Inhibition	%	1.19
	8113784	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.26	CHEMBL5455	Homo sapiens	Inhibition	%	3.26
	8113900	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.56	CHEMBL5455	Homo sapiens	Inhibition	%	-1.56
	8114300	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.52	CHEMBL5455	Homo sapiens	Inhibition	%	3.52
	8114432	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.89	CHEMBL5455	Homo sapiens	Inhibition	%	3.89
	8114708	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.08	CHEMBL5455	Homo sapiens	Inhibition	%	3.08
	8115098	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.99	CHEMBL5455	Homo sapiens	Inhibition	%	1.99
	8115263	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.62	CHEMBL5455	Homo sapiens	Inhibition	%	-1.62
	8115607	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.62	CHEMBL5455	Homo sapiens	Inhibition	%	0.62
	8115964	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	4.12	CHEMBL5455	Homo sapiens	Inhibition	%	4.12
	8116123	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.1	CHEMBL5455	Homo sapiens	Inhibition	%	-0.1
	8116326	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.44	CHEMBL5455	Homo sapiens	Inhibition	%	3.44
	8116550	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.9	CHEMBL5455	Homo sapiens	Inhibition	%	2.9
	8116684	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.14	CHEMBL5455	Homo sapiens	Inhibition	%	0.14
	8116856	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	Inhibition	%	4.0
	8117080	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	7.1	CHEMBL5455	Homo sapiens	Inhibition	%	7.1
	8117251	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.27	CHEMBL5455	Homo sapiens	Inhibition	%	0.27
	8117409	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.11	CHEMBL5455	Homo sapiens	Inhibition	%	4.11
	8117633	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.46	CHEMBL5455	Homo sapiens	Inhibition	%	4.46
	8117763	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.53	CHEMBL5455	Homo sapiens	Inhibition	%	0.53
	8118125	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.73	CHEMBL5455	Homo sapiens	Inhibition	%	2.73
	8118241	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.5	CHEMBL5455	Homo sapiens	Inhibition	%	-1.5
	8118465	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.78	CHEMBL5455	Homo sapiens	Inhibition	%	3.78
	8118637	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.12	CHEMBL5455	Homo sapiens	Inhibition	%	4.12
	8118773	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.4	CHEMBL5455	Homo sapiens	Inhibition	%	3.4
	8118997	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.89	CHEMBL5455	Homo sapiens	Inhibition	%	2.89
	8119044	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.29	CHEMBL5455	Homo sapiens	Inhibition	%	2.29
	8119268	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	76.14	CHEMBL5455	Homo sapiens	Inhibition	%	76.14
	8119427	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.25	CHEMBL5455	Homo sapiens	Inhibition	%	3.25
	8119594	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.62	CHEMBL5455	Homo sapiens	Inhibition	%	-0.62
	8119818	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.06	CHEMBL5455	Homo sapiens	Inhibition	%	-1.06
	8119937	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.25	CHEMBL5455	Homo sapiens	Inhibition	%	0.25
	8120300	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.95	CHEMBL5455	Homo sapiens	Inhibition	%	0.95
	8120460	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.22	CHEMBL5455	Homo sapiens	Inhibition	%	0.22
	8120885	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.88	CHEMBL5455	Homo sapiens	Inhibition	%	5.88
	8121013	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.91	CHEMBL5455	Homo sapiens	Inhibition	%	0.91
	8121409	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.87	CHEMBL5455	Homo sapiens	Inhibition	%	1.87
	8121576	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.64	CHEMBL5455	Homo sapiens	Inhibition	%	0.64
	8121963	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.73	CHEMBL5455	Homo sapiens	Inhibition	%	2.73
	8122084	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.08	CHEMBL5455	Homo sapiens	Inhibition	%	0.08
	8122308	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.17	CHEMBL5455	Homo sapiens	Inhibition	%	-1.17
	8122446	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.2	CHEMBL5455	Homo sapiens	Inhibition	%	2.2
	8122790	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.26	CHEMBL5455	Homo sapiens	Inhibition	%	5.26
	8122957	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.78	CHEMBL5455	Homo sapiens	Inhibition	%	3.78
	8123323	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.56	CHEMBL5455	Homo sapiens	Inhibition	%	2.56
	8123601	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	89.01	CHEMBL5455	Homo sapiens	Inhibition	%	89.01
	8123751	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.59	CHEMBL5455	Homo sapiens	Inhibition	%	2.59
	8124142	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.04	CHEMBL5455	Homo sapiens	Inhibition	%	-0.04
	8124261	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.06	CHEMBL5455	Homo sapiens	Inhibition	%	-0.06
	8124485	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	8.87	CHEMBL5455	Homo sapiens	Inhibition	%	8.87
	8124624	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.4	CHEMBL5455	Homo sapiens	Inhibition	%	0.4
	8124789	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.09	CHEMBL5455	Homo sapiens	Inhibition	%	-0.09
	8125013	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.2	CHEMBL5455	Homo sapiens	Inhibition	%	-1.2
	8125214	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.41	CHEMBL5455	Homo sapiens	Inhibition	%	3.41
	8125344	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.14	CHEMBL5455	Homo sapiens	Inhibition	%	-0.14
	8125568	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.26	CHEMBL5455	Homo sapiens	Inhibition	%	-0.26
	8125736	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.71	CHEMBL5455	Homo sapiens	Inhibition	%	1.71
	8125900	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.42	CHEMBL5455	Homo sapiens	Inhibition	%	-0.42
	8126124	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.22	CHEMBL5455	Homo sapiens	Inhibition	%	-0.22
	8126288	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.01	CHEMBL5455	Homo sapiens	Inhibition	%	4.01
	8126627	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.8	CHEMBL5455	Homo sapiens	Inhibition	%	-0.8
	8126763	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.55	CHEMBL5455	Homo sapiens	Inhibition	%	3.55
	8127109	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.48	CHEMBL5455	Homo sapiens	Inhibition	%	3.48
	8127276	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.56	CHEMBL5455	Homo sapiens	Inhibition	%	3.56
	8127500	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.72	CHEMBL5455	Homo sapiens	Inhibition	%	4.72
	8127642	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.4	CHEMBL5455	Homo sapiens	Inhibition	%	1.4
	8127930	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.66	CHEMBL5455	Homo sapiens	Inhibition	%	2.66
	8128082	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.03	CHEMBL5455	Homo sapiens	Inhibition	%	4.03
	8128306	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.75	CHEMBL5455	Homo sapiens	Inhibition	%	1.75
	8128473	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.27	CHEMBL5455	Homo sapiens	Inhibition	%	-1.27
	8128816	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	50.31	CHEMBL5455	Homo sapiens	Inhibition	%	50.31
	8128953	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.77	CHEMBL5455	Homo sapiens	Inhibition	%	0.77
	8129348	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.22	CHEMBL5455	Homo sapiens	Inhibition	%	0.22
	8129537	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.8	CHEMBL5455	Homo sapiens	Inhibition	%	3.8
	8129900	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.66	CHEMBL5455	Homo sapiens	Inhibition	%	-1.66
	8130061	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.11	CHEMBL5455	Homo sapiens	Inhibition	%	2.11
	8130457	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.05	CHEMBL5455	Homo sapiens	Inhibition	%	-1.05
	8130617	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.99	CHEMBL5455	Homo sapiens	Inhibition	%	5.99
	8130957	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.3	CHEMBL5455	Homo sapiens	Inhibition	%	4.3
	8131096	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	7.01	CHEMBL5455	Homo sapiens	Inhibition	%	7.01
	8131320	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	Inhibition	%	4.0
	8131440	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.42	CHEMBL5455	Homo sapiens	Inhibition	%	4.42
	8131831	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.79	CHEMBL5455	Homo sapiens	Inhibition	%	4.79
	8131972	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.8	CHEMBL5455	Homo sapiens	Inhibition	%	3.8
	8132258	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.2	CHEMBL5455	Homo sapiens	Inhibition	%	3.2
	8132629	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.31	CHEMBL5455	Homo sapiens	Inhibition	%	1.31
	8132797	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.21	CHEMBL5455	Homo sapiens	Inhibition	%	0.21
	8133142	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.01	CHEMBL5455	Homo sapiens	Inhibition	%	0.01
	8133280	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.99	CHEMBL5455	Homo sapiens	Inhibition	%	0.99
	8133504	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.37	CHEMBL5455	Homo sapiens	Inhibition	%	2.37
	8133676	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.71	CHEMBL5455	Homo sapiens	Inhibition	%	-1.71
	8133856	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	7.35	CHEMBL5455	Homo sapiens	Inhibition	%	7.35
	8134228	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.35	CHEMBL5455	Homo sapiens	Inhibition	%	-0.35
	8134388	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.66	CHEMBL5455	Homo sapiens	Inhibition	%	1.66
	8134612	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.83	CHEMBL5455	Homo sapiens	Inhibition	%	2.83
	8134796	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.08	CHEMBL5455	Homo sapiens	Inhibition	%	-2.08
	8134956	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	28.01	CHEMBL5455	Homo sapiens	Inhibition	%	28.01
	8135180	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.53	CHEMBL5455	Homo sapiens	Inhibition	%	3.53
	8135295	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.79	CHEMBL5455	Homo sapiens	Inhibition	%	1.79
	8135660	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.21	CHEMBL5455	Homo sapiens	Inhibition	%	4.21
	8135781	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.44	CHEMBL5455	Homo sapiens	Inhibition	%	2.44
	8136005	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.52	CHEMBL5455	Homo sapiens	Inhibition	%	2.52
	8136173	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.43	CHEMBL5455	Homo sapiens	Inhibition	%	3.43
	8136317	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.91	CHEMBL5455	Homo sapiens	Inhibition	%	4.91
	8136541	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.19	CHEMBL5455	Homo sapiens	Inhibition	%	4.19
	8136607	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	5.04	CHEMBL5455	Homo sapiens	Inhibition	%	5.04
	8136966	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.63	CHEMBL5455	Homo sapiens	Inhibition	%	1.63
	8137129	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.02	CHEMBL5455	Homo sapiens	Inhibition	%	0.02
	8137353	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.38	CHEMBL5455	Homo sapiens	Inhibition	%	2.38
	8137473	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.6	CHEMBL5455	Homo sapiens	Inhibition	%	1.6
	8137845	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.12	CHEMBL5455	Homo sapiens	Inhibition	%	2.12
	8138011	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.84	CHEMBL5455	Homo sapiens	Inhibition	%	-0.84
	8138190	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	43.38	CHEMBL5455	Homo sapiens	Inhibition	%	43.38
	8138414	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.48	CHEMBL5455	Homo sapiens	Inhibition	%	1.48
	8138562	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.8	CHEMBL5455	Homo sapiens	Inhibition	%	-0.8
	8138944	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.55	CHEMBL5455	Homo sapiens	Inhibition	%	1.55
	8139129	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.95	CHEMBL5455	Homo sapiens	Inhibition	%	-1.95
	8139512	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.62	CHEMBL5455	Homo sapiens	Inhibition	%	5.62
	8139626	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.29	CHEMBL5455	Homo sapiens	Inhibition	%	3.29
	8139991	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.0	CHEMBL5455	Homo sapiens	Inhibition	%	5.0
	8140338	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.23	CHEMBL5455	Homo sapiens	Inhibition	%	3.23
	8140497	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.25	CHEMBL5455	Homo sapiens	Inhibition	%	3.25
	8140864	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.36	CHEMBL5455	Homo sapiens	Inhibition	%	3.36
	8140942	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	10.73	CHEMBL5455	Homo sapiens	Inhibition	%	10.73
	8141166	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	39.89	CHEMBL5455	Homo sapiens	Inhibition	%	39.89
	8141296	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.35	CHEMBL5455	Homo sapiens	Inhibition	%	2.35
	8141680	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	5.6	CHEMBL5455	Homo sapiens	Inhibition	%	5.6
	8141799	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.51	CHEMBL5455	Homo sapiens	Inhibition	%	-0.51
	8142023	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.68	CHEMBL5455	Homo sapiens	Inhibition	%	-0.68
	8142184	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	4.35	CHEMBL5455	Homo sapiens	Inhibition	%	4.35
	8142352	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.66	CHEMBL5455	Homo sapiens	Inhibition	%	-1.66
	8142576	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.88	CHEMBL5455	Homo sapiens	Inhibition	%	-1.88
	8142752	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.22	CHEMBL5455	Homo sapiens	Inhibition	%	3.22
	8142901	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.77	CHEMBL5455	Homo sapiens	Inhibition	%	-2.77
	8143125	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.0	CHEMBL5455	Homo sapiens	Inhibition	%	-3.0
	8143280	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.44	CHEMBL5455	Homo sapiens	Inhibition	%	2.44
	8143467	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.93	CHEMBL5455	Homo sapiens	Inhibition	%	3.93
	8143850	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.67	CHEMBL5455	Homo sapiens	Inhibition	%	3.67
	8143964	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.27	CHEMBL5455	Homo sapiens	Inhibition	%	3.27
	8144188	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.7	CHEMBL5455	Homo sapiens	Inhibition	%	2.7
	8144327	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.91	CHEMBL5455	Homo sapiens	Inhibition	%	4.91
	8144681	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.78	CHEMBL5455	Homo sapiens	Inhibition	%	4.78
	8144834	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.25	CHEMBL5455	Homo sapiens	Inhibition	%	2.25
	8145195	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.42	CHEMBL5455	Homo sapiens	Inhibition	%	4.42
	8145508	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	62.33	CHEMBL5455	Homo sapiens	Inhibition	%	62.33
	8145632	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.02	CHEMBL5455	Homo sapiens	Inhibition	%	1.02
	8145856	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.51	CHEMBL5455	Homo sapiens	Inhibition	%	1.51
	8146017	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	11.08	CHEMBL5455	Homo sapiens	Inhibition	%	11.08
	8146361	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.33	CHEMBL5455	Homo sapiens	Inhibition	%	0.33
	8146521	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	7.51	CHEMBL5455	Homo sapiens	Inhibition	%	7.51
	8146912	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.98	CHEMBL5455	Homo sapiens	Inhibition	%	-1.98
	8147081	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.03	CHEMBL5455	Homo sapiens	Inhibition	%	2.03
	8147447	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.27	CHEMBL5455	Homo sapiens	Inhibition	%	1.27
	8147600	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.24	CHEMBL5455	Homo sapiens	Inhibition	%	2.24
	8147787	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.1	CHEMBL5455	Homo sapiens	Inhibition	%	4.1
	8148011	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.27	CHEMBL5455	Homo sapiens	Inhibition	%	3.27
	8148169	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.17	CHEMBL5455	Homo sapiens	Inhibition	%	5.17
	8148507	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.88	CHEMBL5455	Homo sapiens	Inhibition	%	1.88
	8148646	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.94	CHEMBL5455	Homo sapiens	Inhibition	%	3.94
	8148870	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.31	CHEMBL5455	Homo sapiens	Inhibition	%	3.31
	8149008	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.82	CHEMBL5455	Homo sapiens	Inhibition	%	4.82
	8149167	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.64	CHEMBL5455	Homo sapiens	Inhibition	%	1.64
	8149391	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.82	CHEMBL5455	Homo sapiens	Inhibition	%	0.82
	8149525	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.26	CHEMBL5455	Homo sapiens	Inhibition	%	4.26
	8149847	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.18	CHEMBL5455	Homo sapiens	Inhibition	%	5.18
	8150196	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.02	CHEMBL5455	Homo sapiens	Inhibition	%	0.02
	8150356	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	22.52	CHEMBL5455	Homo sapiens	Inhibition	%	22.52
	8150700	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.58	CHEMBL5455	Homo sapiens	Inhibition	%	-0.58
	8150865	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	77.9	CHEMBL5455	Homo sapiens	Inhibition	%	77.9
	8151252	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.18	CHEMBL5455	Homo sapiens	Inhibition	%	-3.18
	8151429	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.81	CHEMBL5455	Homo sapiens	Inhibition	%	1.81
	8151791	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.38	CHEMBL5455	Homo sapiens	Inhibition	%	2.38
	8151945	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.15	CHEMBL5455	Homo sapiens	Inhibition	%	3.15
	8152169	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.54	CHEMBL5455	Homo sapiens	Inhibition	%	2.54
	8152357	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.01	CHEMBL5455	Homo sapiens	Inhibition	%	4.01
	8152515	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.92	CHEMBL5455	Homo sapiens	Inhibition	%	3.92
	8152853	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.93	CHEMBL5455	Homo sapiens	Inhibition	%	3.93
	8153216	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.89	CHEMBL5455	Homo sapiens	Inhibition	%	2.89
	8153353	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.5	CHEMBL5455	Homo sapiens	Inhibition	%	4.5
	8153734	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.27	CHEMBL5455	Homo sapiens	Inhibition	%	0.27
	8153867	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.48	CHEMBL5455	Homo sapiens	Inhibition	%	4.48
	8154091	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.8	CHEMBL5455	Homo sapiens	Inhibition	%	4.8
	8154188	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	7.85	CHEMBL5455	Homo sapiens	Inhibition	%	7.85
	8154538	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.11	CHEMBL5455	Homo sapiens	Inhibition	%	0.11
	8154697	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.17	CHEMBL5455	Homo sapiens	Inhibition	%	0.17
	8154921	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.47	CHEMBL5455	Homo sapiens	Inhibition	%	1.47
	8155041	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.35	CHEMBL5455	Homo sapiens	Inhibition	%	0.35
	8155217	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	86.81	CHEMBL5455	Homo sapiens	Inhibition	%	86.81
	8155441	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.08	CHEMBL5455	Homo sapiens	Inhibition	%	5.08
	8155602	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.34	CHEMBL5455	Homo sapiens	Inhibition	%	-3.34
	8155780	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.57	CHEMBL5455	Homo sapiens	Inhibition	%	1.57
	8156004	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.04	CHEMBL5455	Homo sapiens	Inhibition	%	2.04
	8156142	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.3	CHEMBL5455	Homo sapiens	Inhibition	%	2.3
	8156354	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.65	CHEMBL5455	Homo sapiens	Inhibition	%	4.65
	8156728	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.72	CHEMBL5455	Homo sapiens	Inhibition	%	2.72
	8156871	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.8	CHEMBL5455	Homo sapiens	Inhibition	%	2.8
	8157095	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.88	CHEMBL5455	Homo sapiens	Inhibition	%	4.88
	8157215	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.58	CHEMBL5455	Homo sapiens	Inhibition	%	1.58
	8157580	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.74	CHEMBL5455	Homo sapiens	Inhibition	%	2.74
	8157710	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.49	CHEMBL5455	Homo sapiens	Inhibition	%	2.49
	8157934	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.63	CHEMBL5455	Homo sapiens	Inhibition	%	2.63
	8158095	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.24	CHEMBL5455	Homo sapiens	Inhibition	%	2.24
	8158345	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.35	CHEMBL5455	Homo sapiens	Inhibition	%	3.35
	8158503	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.28	CHEMBL5455	Homo sapiens	Inhibition	%	5.28
	8158727	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.19	CHEMBL5455	Homo sapiens	Inhibition	%	5.19
	8158896	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.89	CHEMBL5455	Homo sapiens	Inhibition	%	2.89
	8159255	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.88	CHEMBL5455	Homo sapiens	Inhibition	%	3.88
	8159375	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.33	CHEMBL5455	Homo sapiens	Inhibition	%	2.33
	8159599	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.15	CHEMBL5455	Homo sapiens	Inhibition	%	1.15
	8159730	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.45	CHEMBL5455	Homo sapiens	Inhibition	%	4.45
	8160095	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.41	CHEMBL5455	Homo sapiens	Inhibition	%	-0.41
	8160232	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.37	CHEMBL5455	Homo sapiens	Inhibition	%	3.37
	8160606	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.78	CHEMBL5455	Homo sapiens	Inhibition	%	-2.78
	8160676	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.78	CHEMBL5455	Homo sapiens	Inhibition	%	4.78
	8160900	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.73	CHEMBL5455	Homo sapiens	Inhibition	%	7.73
	8161050	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.04	CHEMBL5455	Homo sapiens	Inhibition	%	2.04
	8161417	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	10.48	CHEMBL5455	Homo sapiens	Inhibition	%	10.48
	8161542	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.34	CHEMBL5455	Homo sapiens	Inhibition	%	2.34
	8161766	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.81	CHEMBL5455	Homo sapiens	Inhibition	%	1.81
	8161904	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.66	CHEMBL5455	Homo sapiens	Inhibition	%	4.66
	8162258	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.59	CHEMBL5455	Homo sapiens	Inhibition	%	3.59
	8162418	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.57	CHEMBL5455	Homo sapiens	Inhibition	%	1.57
	8162671	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.6	CHEMBL5455	Homo sapiens	Inhibition	%	2.6
	8163043	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	12.31	CHEMBL5455	Homo sapiens	Inhibition	%	12.31
	8163212	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.45	CHEMBL5455	Homo sapiens	Inhibition	%	3.45
	8163570	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.5	CHEMBL5455	Homo sapiens	Inhibition	%	3.5
	8163917	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.99	CHEMBL5455	Homo sapiens	Inhibition	%	0.99
	8164051	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	61.38	CHEMBL5455	Homo sapiens	Inhibition	%	61.38
	8164415	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.11	CHEMBL5455	Homo sapiens	Inhibition	%	-0.11
	8164570	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.23	CHEMBL5455	Homo sapiens	Inhibition	%	6.23
	8164938	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.56	CHEMBL5455	Homo sapiens	Inhibition	%	-2.56
	8165232	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	44.29	CHEMBL5455	Homo sapiens	Inhibition	%	44.29
	8165373	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	7.78	CHEMBL5455	Homo sapiens	Inhibition	%	7.78
	8165597	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.25	CHEMBL5455	Homo sapiens	Inhibition	%	2.25
	8165740	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	47.95	CHEMBL5455	Homo sapiens	Inhibition	%	47.95
	8166090	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.5	CHEMBL5455	Homo sapiens	Inhibition	%	2.5
	8166228	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.34	CHEMBL5455	Homo sapiens	Inhibition	%	2.34
	8166582	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.34	CHEMBL5455	Homo sapiens	Inhibition	%	2.34
	8166907	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	10.57	CHEMBL5455	Homo sapiens	Inhibition	%	10.57
	8166995	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.26	CHEMBL5455	Homo sapiens	Inhibition	%	2.26
	8167219	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.8	CHEMBL5455	Homo sapiens	Inhibition	%	2.8
	8167360	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	17.08	CHEMBL5455	Homo sapiens	Inhibition	%	17.08
	8167524	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.2	CHEMBL5455	Homo sapiens	Inhibition	%	2.2
	8167748	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.36	CHEMBL5455	Homo sapiens	Inhibition	%	2.36
	8167881	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.98	CHEMBL5455	Homo sapiens	Inhibition	%	2.98
	8168229	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.59	CHEMBL5455	Homo sapiens	Inhibition	%	0.59
	8168370	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	81.27	CHEMBL5455	Homo sapiens	Inhibition	%	81.27
	8168594	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.0	CHEMBL5455	Homo sapiens	Inhibition	%	3.0
	8168730	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.76	CHEMBL5455	Homo sapiens	Inhibition	%	-0.76
	8168894	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.07	CHEMBL5455	Homo sapiens	Inhibition	%	7.07
	8169118	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	34.26	CHEMBL5455	Homo sapiens	Inhibition	%	34.26
	8169260	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.68	CHEMBL5455	Homo sapiens	Inhibition	%	2.68
	8169564	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	80.63	CHEMBL5455	Homo sapiens	Inhibition	%	80.63
	8169922	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.17	CHEMBL5455	Homo sapiens	Inhibition	%	3.17
	8170067	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.31	CHEMBL5455	Homo sapiens	Inhibition	%	1.31
	8170416	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.06	CHEMBL5455	Homo sapiens	Inhibition	%	2.06
	8170556	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.7	CHEMBL5455	Homo sapiens	Inhibition	%	2.7
	8170780	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.17	CHEMBL5455	Homo sapiens	Inhibition	%	2.17
	8170915	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.64	CHEMBL5455	Homo sapiens	Inhibition	%	1.64
	8171112	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.53	CHEMBL5455	Homo sapiens	Inhibition	%	1.53
	8171336	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.05	CHEMBL5455	Homo sapiens	Inhibition	%	3.05
	8171553	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.83	CHEMBL5455	Homo sapiens	Inhibition	%	2.83
	8171694	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	76.51	CHEMBL5455	Homo sapiens	Inhibition	%	76.51
	8172071	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.31	CHEMBL5455	Homo sapiens	Inhibition	%	1.31
	8172203	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.83	CHEMBL5455	Homo sapiens	Inhibition	%	2.83
	8172427	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.03	CHEMBL5455	Homo sapiens	Inhibition	%	4.03
	8172555	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.3	CHEMBL5455	Homo sapiens	Inhibition	%	0.3
	8172921	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.19	CHEMBL5455	Homo sapiens	Inhibition	%	5.19
	8173057	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-3.2	CHEMBL5455	Homo sapiens	Inhibition	%	-3.2
	8173446	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.38	CHEMBL5455	Homo sapiens	Inhibition	%	3.38
	8173587	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.38	CHEMBL5455	Homo sapiens	Inhibition	%	4.38
	8173898	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.34	CHEMBL5455	Homo sapiens	Inhibition	%	5.34
	8174254	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.96	CHEMBL5455	Homo sapiens	Inhibition	%	1.96
	8174402	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	4.84	CHEMBL5455	Homo sapiens	Inhibition	%	4.84
	8174626	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.39	CHEMBL5455	Homo sapiens	Inhibition	%	1.39
	8174748	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.97	CHEMBL5455	Homo sapiens	Inhibition	%	2.97
	8175115	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.04	CHEMBL5455	Homo sapiens	Inhibition	%	4.04
	8175251	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	5.26	CHEMBL5455	Homo sapiens	Inhibition	%	5.26
	8175507	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.67	CHEMBL5455	Homo sapiens	Inhibition	%	2.67
	8175731	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.63	CHEMBL5455	Homo sapiens	Inhibition	%	2.63
	8175894	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.04	CHEMBL5455	Homo sapiens	Inhibition	%	2.04
	8176047	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	79.44	CHEMBL5455	Homo sapiens	Inhibition	%	79.44
	8176271	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	12.77	CHEMBL5455	Homo sapiens	Inhibition	%	12.77
	8176420	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.83	CHEMBL5455	Homo sapiens	Inhibition	%	0.83
	8176776	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.17	CHEMBL5455	Homo sapiens	Inhibition	%	5.17
	8176906	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.05	CHEMBL5455	Homo sapiens	Inhibition	%	-0.05
	8177272	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.28	CHEMBL5455	Homo sapiens	Inhibition	%	2.28
	8177410	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-4.0	CHEMBL5455	Homo sapiens	Inhibition	%	-4.0
	8177634	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.43	CHEMBL5455	Homo sapiens	Inhibition	%	3.43
	8177798	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.85	CHEMBL5455	Homo sapiens	Inhibition	%	5.85
	8177938	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.71	CHEMBL5455	Homo sapiens	Inhibition	%	2.71
	8178162	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.85	CHEMBL5455	Homo sapiens	Inhibition	%	2.85
	8178250	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.37	CHEMBL5455	Homo sapiens	Inhibition	%	8.37
	8178474	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.17	CHEMBL5455	Homo sapiens	Inhibition	%	2.17
	8178601	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.05	CHEMBL5455	Homo sapiens	Inhibition	%	3.05
	8178974	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.59	CHEMBL5455	Homo sapiens	Inhibition	%	1.59
	8179097	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.67	CHEMBL5455	Homo sapiens	Inhibition	%	2.67
	8179465	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.4	CHEMBL5455	Homo sapiens	Inhibition	%	2.4
	8179602	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	25.53	CHEMBL5455	Homo sapiens	Inhibition	%	25.53
	8179826	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.38	CHEMBL5455	Homo sapiens	Inhibition	%	1.38
	8180083	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.95	CHEMBL5455	Homo sapiens	Inhibition	%	3.95
	8180237	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.14	CHEMBL5455	Homo sapiens	Inhibition	%	6.14
	8180617	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	13.04	CHEMBL5455	Homo sapiens	Inhibition	%	13.04
	8180765	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.6	CHEMBL5455	Homo sapiens	Inhibition	%	0.6
	8181122	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	8.11	CHEMBL5455	Homo sapiens	Inhibition	%	8.11
	8181253	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.73	CHEMBL5455	Homo sapiens	Inhibition	%	-0.73
	8181477	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.91	CHEMBL5455	Homo sapiens	Inhibition	%	-2.91
	8181617	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.8	CHEMBL5455	Homo sapiens	Inhibition	%	3.8
	8181980	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.4	CHEMBL5455	Homo sapiens	Inhibition	%	10.4
	8182143	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.07	CHEMBL5455	Homo sapiens	Inhibition	%	3.07
	8182507	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.21	CHEMBL5455	Homo sapiens	Inhibition	%	3.21
	8182823	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.06	CHEMBL5455	Homo sapiens	Inhibition	%	3.06
	8182945	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.58	CHEMBL5455	Homo sapiens	Inhibition	%	2.58
	8183318	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.8	CHEMBL5455	Homo sapiens	Inhibition	%	1.8
	8183447	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.23	CHEMBL5455	Homo sapiens	Inhibition	%	3.23
	8183671	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.13	CHEMBL5455	Homo sapiens	Inhibition	%	-0.13
	8183813	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.67	CHEMBL5455	Homo sapiens	Inhibition	%	1.67
	8184173	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.43	CHEMBL5455	Homo sapiens	Inhibition	%	1.43
	8184439	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.43	CHEMBL5455	Homo sapiens	Inhibition	%	3.43
	8184586	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.96	CHEMBL5455	Homo sapiens	Inhibition	%	1.96
	8184967	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.45	CHEMBL5455	Homo sapiens	Inhibition	%	3.45
	8185116	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.4	CHEMBL5455	Homo sapiens	Inhibition	%	0.4
	8185340	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.32	CHEMBL5455	Homo sapiens	Inhibition	%	0.32
	8185471	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	39.43	CHEMBL5455	Homo sapiens	Inhibition	%	39.43
	8185826	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-3.39	CHEMBL5455	Homo sapiens	Inhibition	%	-3.39
	8185965	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.97	CHEMBL5455	Homo sapiens	Inhibition	%	2.97
	8186330	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.66	CHEMBL5455	Homo sapiens	Inhibition	%	2.66
	8186494	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.26	CHEMBL5455	Homo sapiens	Inhibition	%	4.26
	8186718	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.03	CHEMBL5455	Homo sapiens	Inhibition	%	3.03
	8186857	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.35	CHEMBL5455	Homo sapiens	Inhibition	%	3.35
	8187179	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.69	CHEMBL5455	Homo sapiens	Inhibition	%	1.69
	8187303	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.42	CHEMBL5455	Homo sapiens	Inhibition	%	3.42
	8187527	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.41	CHEMBL5455	Homo sapiens	Inhibition	%	3.41
	8187675	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.42	CHEMBL5455	Homo sapiens	Inhibition	%	2.42
	8188028	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.22	CHEMBL5455	Homo sapiens	Inhibition	%	1.22
	8188171	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.52	CHEMBL5455	Homo sapiens	Inhibition	%	2.52
	8188395	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.84	CHEMBL5455	Homo sapiens	Inhibition	%	2.84
	8188530	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.5	CHEMBL5455	Homo sapiens	Inhibition	%	0.5
	8188804	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.05	CHEMBL5455	Homo sapiens	Inhibition	%	4.05
	8188952	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.5	CHEMBL5455	Homo sapiens	Inhibition	%	1.5
	8189176	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.26	CHEMBL5455	Homo sapiens	Inhibition	%	1.26
	8189332	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	6.43	CHEMBL5455	Homo sapiens	Inhibition	%	6.43
	8189705	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.52	CHEMBL5455	Homo sapiens	Inhibition	%	0.52
	8189837	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.69	CHEMBL5455	Homo sapiens	Inhibition	%	2.69
	8190193	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.24	CHEMBL5455	Homo sapiens	Inhibition	%	3.24
	8190333	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.53	CHEMBL5455	Homo sapiens	Inhibition	%	2.53
	8190557	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.8	CHEMBL5455	Homo sapiens	Inhibition	%	3.8
	8190694	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.57	CHEMBL5455	Homo sapiens	Inhibition	%	2.57
	8191082	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.04	CHEMBL5455	Homo sapiens	Inhibition	%	5.04
	8191220	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.36	CHEMBL5455	Homo sapiens	Inhibition	%	3.36
	8191540	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.94	CHEMBL5455	Homo sapiens	Inhibition	%	1.94
	8191886	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	8.88	CHEMBL5455	Homo sapiens	Inhibition	%	8.88
	8192035	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.16	CHEMBL5455	Homo sapiens	Inhibition	%	2.16
	8192388	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.89	CHEMBL5455	Homo sapiens	Inhibition	%	1.89
	8192756	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.38	CHEMBL5455	Homo sapiens	Inhibition	%	2.38
	8192892	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.07	CHEMBL5455	Homo sapiens	Inhibition	%	0.07
	8193164	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.83	CHEMBL5455	Homo sapiens	Inhibition	%	6.83
	8193533	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.37	CHEMBL5455	Homo sapiens	Inhibition	%	5.37
	8193690	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.03	CHEMBL5455	Homo sapiens	Inhibition	%	3.03
	8194063	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.72	CHEMBL5455	Homo sapiens	Inhibition	%	-2.72
	8194194	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.01	CHEMBL5455	Homo sapiens	Inhibition	%	6.01
	8194418	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.91	CHEMBL5455	Homo sapiens	Inhibition	%	2.91
	8194549	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.41	CHEMBL5455	Homo sapiens	Inhibition	%	4.41
	8194916	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.92	CHEMBL5455	Homo sapiens	Inhibition	%	3.92
	8195049	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.72	CHEMBL5455	Homo sapiens	Inhibition	%	2.72
	8195273	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.24	CHEMBL5455	Homo sapiens	Inhibition	%	3.24
	8195437	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.95	CHEMBL5455	Homo sapiens	Inhibition	%	1.95
	8195576	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.7	CHEMBL5455	Homo sapiens	Inhibition	%	6.7
	8195800	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.6	CHEMBL5455	Homo sapiens	Inhibition	%	3.6
	8195898	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.4	CHEMBL5455	Homo sapiens	Inhibition	%	1.4
	8196239	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.75	CHEMBL5455	Homo sapiens	Inhibition	%	1.75
	8196389	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.33	CHEMBL5455	Homo sapiens	Inhibition	%	2.33
	8196613	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.61	CHEMBL5455	Homo sapiens	Inhibition	%	2.61
	8196741	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.09	CHEMBL5455	Homo sapiens	Inhibition	%	2.09
	8197106	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.6	CHEMBL5455	Homo sapiens	Inhibition	%	1.6
	8197243	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.16	CHEMBL5455	Homo sapiens	Inhibition	%	0.16
	8197467	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.05	CHEMBL5455	Homo sapiens	Inhibition	%	0.05
	8197518	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.18	CHEMBL5455	Homo sapiens	Inhibition	%	3.18
	8197742	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.59	CHEMBL5455	Homo sapiens	Inhibition	%	3.59
	8197882	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.24	CHEMBL5455	Homo sapiens	Inhibition	%	-0.24
	8198039	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.46	CHEMBL5455	Homo sapiens	Inhibition	%	3.46
	8198263	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.58	CHEMBL5455	Homo sapiens	Inhibition	%	2.58
	8198401	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.78	CHEMBL5455	Homo sapiens	Inhibition	%	-3.78
	8198755	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.54	CHEMBL5455	Homo sapiens	Inhibition	%	3.54
	8198886	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.08	CHEMBL5455	Homo sapiens	Inhibition	%	4.08
	8199110	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	7.35	CHEMBL5455	Homo sapiens	Inhibition	%	7.35
	8199258	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.37	CHEMBL5455	Homo sapiens	Inhibition	%	3.37
	8199616	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.55	CHEMBL5455	Homo sapiens	Inhibition	%	2.55
	8199779	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.89	CHEMBL5455	Homo sapiens	Inhibition	%	2.89
	8200141	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.6	CHEMBL5455	Homo sapiens	Inhibition	%	4.6
	8200245	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.21	CHEMBL5455	Homo sapiens	Inhibition	%	2.21
	8200469	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.87	CHEMBL5455	Homo sapiens	Inhibition	%	0.87
	8200584	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.02	CHEMBL5455	Homo sapiens	Inhibition	%	3.02
	8200958	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.64	CHEMBL5455	Homo sapiens	Inhibition	%	5.64
	8201088	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.87	CHEMBL5455	Homo sapiens	Inhibition	%	1.87
	8201312	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.21	CHEMBL5455	Homo sapiens	Inhibition	%	1.21
	8201447	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.42	CHEMBL5455	Homo sapiens	Inhibition	%	2.42
	8201804	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.52	CHEMBL5455	Homo sapiens	Inhibition	%	-0.52
	8202083	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.48	CHEMBL5455	Homo sapiens	Inhibition	%	2.48
	8202223	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.38	CHEMBL5455	Homo sapiens	Inhibition	%	0.38
	8202614	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.75	CHEMBL5455	Homo sapiens	Inhibition	%	2.75
	8202739	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.57	CHEMBL5455	Homo sapiens	Inhibition	%	2.57
	8202963	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.31	CHEMBL5455	Homo sapiens	Inhibition	%	3.31
	8203093	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.21	CHEMBL5455	Homo sapiens	Inhibition	%	3.21
	8203448	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	15.17	CHEMBL5455	Homo sapiens	Inhibition	%	15.17
	8203594	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.11	CHEMBL5455	Homo sapiens	Inhibition	%	3.11
	8203952	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.61	CHEMBL5455	Homo sapiens	Inhibition	%	3.61
	8204118	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.48	CHEMBL5455	Homo sapiens	Inhibition	%	1.48
	8204342	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.34	CHEMBL5455	Homo sapiens	Inhibition	%	2.34
	8204479	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.23	CHEMBL5455	Homo sapiens	Inhibition	%	4.23
	8204808	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.62	CHEMBL5455	Homo sapiens	Inhibition	%	1.62
	8204923	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.22	CHEMBL5455	Homo sapiens	Inhibition	%	2.22
	8205147	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.19	CHEMBL5455	Homo sapiens	Inhibition	%	7.19
	8205296	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.42	CHEMBL5455	Homo sapiens	Inhibition	%	3.42
	8205656	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.51	CHEMBL5455	Homo sapiens	Inhibition	%	2.51
	8205795	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.62	CHEMBL5455	Homo sapiens	Inhibition	%	4.62
	8206151	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.2	CHEMBL5455	Homo sapiens	Inhibition	%	-1.2
	8206427	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.85	CHEMBL5455	Homo sapiens	Inhibition	%	2.85
	8206570	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.93	CHEMBL5455	Homo sapiens	Inhibition	%	-2.93
	8206794	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-3.65	CHEMBL5455	Homo sapiens	Inhibition	%	-3.65
	8206974	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.93	CHEMBL5455	Homo sapiens	Inhibition	%	2.93
	8207324	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.08	CHEMBL5455	Homo sapiens	Inhibition	%	3.08
	8207454	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.15	CHEMBL5455	Homo sapiens	Inhibition	%	4.15
	8207810	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	56.09	CHEMBL5455	Homo sapiens	Inhibition	%	56.09
	8207955	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.2	CHEMBL5455	Homo sapiens	Inhibition	%	2.2
	8208179	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.72	CHEMBL5455	Homo sapiens	Inhibition	%	5.72
	8208311	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.39	CHEMBL5455	Homo sapiens	Inhibition	%	3.39
	8208701	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.76	CHEMBL5455	Homo sapiens	Inhibition	%	1.76
	8208834	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	8.97	CHEMBL5455	Homo sapiens	Inhibition	%	8.97
	8209163	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.07	CHEMBL5455	Homo sapiens	Inhibition	%	-0.07
	8209503	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.12	CHEMBL5455	Homo sapiens	Inhibition	%	2.12
	8209653	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.53	CHEMBL5455	Homo sapiens	Inhibition	%	4.53
	8210013	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.14	CHEMBL5455	Homo sapiens	Inhibition	%	2.14
	8210154	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.28	CHEMBL5455	Homo sapiens	Inhibition	%	2.28
	8210378	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	Inhibition	%	4.0
	8210514	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.39	CHEMBL5455	Homo sapiens	Inhibition	%	-3.39
	8210773	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.32	CHEMBL5455	Homo sapiens	Inhibition	%	2.32
	8211141	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.47	CHEMBL5455	Homo sapiens	Inhibition	%	3.47
	8211311	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.95	CHEMBL5455	Homo sapiens	Inhibition	%	2.95
	8211658	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.47	CHEMBL5455	Homo sapiens	Inhibition	%	4.47
	8211787	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.04	CHEMBL5455	Homo sapiens	Inhibition	%	3.04
	8212011	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.83	CHEMBL5455	Homo sapiens	Inhibition	%	3.83
	8212143	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.25	CHEMBL5455	Homo sapiens	Inhibition	%	4.25
	8212508	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.98	CHEMBL5455	Homo sapiens	Inhibition	%	1.98
	8212641	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.93	CHEMBL5455	Homo sapiens	Inhibition	%	3.93
	8213035	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.99	CHEMBL5455	Homo sapiens	Inhibition	%	2.99
	8213164	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.84	CHEMBL5455	Homo sapiens	Inhibition	%	2.84
	8213388	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.51	CHEMBL5455	Homo sapiens	Inhibition	%	3.51
	8213492	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.23	CHEMBL5455	Homo sapiens	Inhibition	%	0.23
	8213829	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.07	CHEMBL5455	Homo sapiens	Inhibition	%	3.07
	8213976	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.35	CHEMBL5455	Homo sapiens	Inhibition	%	1.35
	8214200	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.53	CHEMBL5455	Homo sapiens	Inhibition	%	2.53
	8214337	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.81	CHEMBL5455	Homo sapiens	Inhibition	%	3.81
	8214695	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.5	CHEMBL5455	Homo sapiens	Inhibition	%	2.5
	8214847	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.54	CHEMBL5455	Homo sapiens	Inhibition	%	-4.54
	8215098	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.83	CHEMBL5455	Homo sapiens	Inhibition	%	1.83
	8215322	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.13	CHEMBL5455	Homo sapiens	Inhibition	%	3.13
	8215475	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.74	CHEMBL5455	Homo sapiens	Inhibition	%	3.74
	8215639	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.3	CHEMBL5455	Homo sapiens	Inhibition	%	3.3
	8215982	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.45	CHEMBL5455	Homo sapiens	Inhibition	%	4.45
	8216325	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.79	CHEMBL5455	Homo sapiens	Inhibition	%	1.79
	8216461	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.11	CHEMBL5455	Homo sapiens	Inhibition	%	7.11
	8216823	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.43	CHEMBL5455	Homo sapiens	Inhibition	%	2.43
	8216957	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.04	CHEMBL5455	Homo sapiens	Inhibition	%	4.04
	8217181	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.25	CHEMBL5455	Homo sapiens	Inhibition	%	4.25
	8217355	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.55	CHEMBL5455	Homo sapiens	Inhibition	%	0.55
	8217710	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.71	CHEMBL5455	Homo sapiens	Inhibition	%	2.71
	8217811	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.1	CHEMBL5455	Homo sapiens	Inhibition	%	-3.1
	8218035	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.0	CHEMBL5455	Homo sapiens	Inhibition	%	-3.0
	8218150	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.16	CHEMBL5455	Homo sapiens	Inhibition	%	2.16
	8218501	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.87	CHEMBL5455	Homo sapiens	Inhibition	%	1.87
	8218644	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.11	CHEMBL5455	Homo sapiens	Inhibition	%	5.11
	8218999	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	10.74	CHEMBL5455	Homo sapiens	Inhibition	%	10.74
	8219159	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.55	CHEMBL5455	Homo sapiens	Inhibition	%	0.55
	8219383	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.54	CHEMBL5455	Homo sapiens	Inhibition	%	0.54
	8219633	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.03	CHEMBL5455	Homo sapiens	Inhibition	%	2.03
	8219794	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.28	CHEMBL5455	Homo sapiens	Inhibition	%	4.28
	8219963	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.52	CHEMBL5455	Homo sapiens	Inhibition	%	3.52
	8220187	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.9	CHEMBL5455	Homo sapiens	Inhibition	%	2.9
	8220316	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	20.12	CHEMBL5455	Homo sapiens	Inhibition	%	20.12
	8220654	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.43	CHEMBL5455	Homo sapiens	Inhibition	%	2.43
	8220792	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.19	CHEMBL5455	Homo sapiens	Inhibition	%	4.19
	8221016	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.81	CHEMBL5455	Homo sapiens	Inhibition	%	6.81
	8221152	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.98	CHEMBL5455	Homo sapiens	Inhibition	%	0.98
	8221509	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	18.5	CHEMBL5455	Homo sapiens	Inhibition	%	18.5
	8221674	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.4	CHEMBL5455	Homo sapiens	Inhibition	%	0.4
	8222029	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.13	CHEMBL5455	Homo sapiens	Inhibition	%	3.13
	8222351	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.69	CHEMBL5455	Homo sapiens	Inhibition	%	1.69
	8222485	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.53	CHEMBL5455	Homo sapiens	Inhibition	%	2.53
	8222827	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.63	CHEMBL5455	Homo sapiens	Inhibition	%	3.63
	8222971	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.91	CHEMBL5455	Homo sapiens	Inhibition	%	3.91
	8223195	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	17.07	CHEMBL5455	Homo sapiens	Inhibition	%	17.07
	8223324	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.28	CHEMBL5455	Homo sapiens	Inhibition	%	2.28
	8223709	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.72	CHEMBL5455	Homo sapiens	Inhibition	%	1.72
	8223959	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.14	CHEMBL5455	Homo sapiens	Inhibition	%	3.14
	8224121	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.04	CHEMBL5455	Homo sapiens	Inhibition	%	5.04
	8224515	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.85	CHEMBL5455	Homo sapiens	Inhibition	%	2.85
	8224650	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.94	CHEMBL5455	Homo sapiens	Inhibition	%	2.94
	8224874	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.74	CHEMBL5455	Homo sapiens	Inhibition	%	3.74
	8224988	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.07	CHEMBL5455	Homo sapiens	Inhibition	%	2.07
	8225346	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.6	CHEMBL5455	Homo sapiens	Inhibition	%	3.6
	8225484	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.87	CHEMBL5455	Homo sapiens	Inhibition	%	0.87
	8225708	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.9	CHEMBL5455	Homo sapiens	Inhibition	%	0.9
	8225843	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	63.66	CHEMBL5455	Homo sapiens	Inhibition	%	63.66
	8226001	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.12	CHEMBL5455	Homo sapiens	Inhibition	%	-0.12
	8226225	CHEMBL1962287	GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.18	CHEMBL5455	Homo sapiens	Inhibition	%	-0.18
	8226350	CHEMBL1962286	GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.46	CHEMBL5455	Homo sapiens	Inhibition	%	3.46
inactive	9598747	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598748	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598749	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	398.11	CHEMBL5455	Homo sapiens	pKi		6.4
active	9598750	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	1584.89	CHEMBL5455	Homo sapiens	pKi		5.8
active	9598751	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	39.81	CHEMBL5455	Homo sapiens	pKi		7.4
active	9598752	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	251.19	CHEMBL5455	Homo sapiens	pKi		6.6
inactive	9598753	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598754	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598755	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598756	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598757	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598758	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598759	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598760	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598761	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598762	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598763	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598764	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598765	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598766	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598767	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598768	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9598769	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598770	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598771	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	7.943	CHEMBL5455	Homo sapiens	pKi		8.1
inactive	9598772	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598773	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598774	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598775	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598776	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598777	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL5455	Homo sapiens	pKi		6.1
inactive	9598778	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598779	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598780	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	158.49	CHEMBL5455	Homo sapiens	pKi		6.8
inactive	9598781	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598782	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	125.89	CHEMBL5455	Homo sapiens	pKi		6.9
active	9598783	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598784	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598785	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598786	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598787	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	398.11	CHEMBL5455	Homo sapiens	pKi		6.4
inactive	9598788	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598789	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598790	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	398.11	CHEMBL5455	Homo sapiens	pKi		6.4
inactive	9598791	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598792	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
active	9598793	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598794	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598795	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598796	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598797	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598798	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	31.62	CHEMBL5455	Homo sapiens	pKi		7.5
inactive	9598799	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598800	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598801	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598802	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	50.12	CHEMBL5455	Homo sapiens	pKi		7.3
inactive	9598803	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598804	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598805	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598806	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598807	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598808	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598809	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598810	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598811	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598812	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598813	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598814	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598815	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598816	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598817	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598818	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
active	9598819	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9598820	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598821	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598822	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	501.19	CHEMBL5455	Homo sapiens	pKi		6.3
inactive	9598823	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598824	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598825	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	794.33	CHEMBL5455	Homo sapiens	pKi		6.1
inactive	9598826	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598827	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598828	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598829	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598830	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598831	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598832	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598833	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598834	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598835	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598836	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598837	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598838	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598839	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598840	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598841	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598842	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	158.49	CHEMBL5455	Homo sapiens	pKi		6.8
inactive	9598843	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598844	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598845	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598846	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598847	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598848	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598849	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598850	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598851	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598852	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598853	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598854	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598855	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	316.23	CHEMBL5455	Homo sapiens	pKi		6.5
inactive	9598856	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598857	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598858	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9598859	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9598860	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598861	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598862	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598863	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598864	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598865	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598866	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598867	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598868	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598869	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9598870	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602436	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602437	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	630.96	CHEMBL5455	Homo sapiens	pKi		6.2
inactive	9602438	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602439	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602440	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	1584.89	CHEMBL5455	Homo sapiens	pKi		5.8
inactive	9602441	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602442	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602443	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602444	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602445	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602446	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602447	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602448	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602449	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602450	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602451	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602452	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602453	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602454	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602455	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602456	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602457	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602458	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602459	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602460	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602461	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602462	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602463	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602464	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602465	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602466	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	=	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602467	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602468	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	398.11	CHEMBL5455	Homo sapiens	pKi		6.4
inactive	9602469	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602470	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	501.19	CHEMBL5455	Homo sapiens	pKi		6.3
inactive	9602471	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602472	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602473	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602474	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602475	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602476	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602477	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602478	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602479	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602480	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602481	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602482	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602483	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602484	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602485	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602486	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602487	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602488	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602489	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602490	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9602491	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602492	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602493	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602494	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	316.23	CHEMBL5455	Homo sapiens	pKi		6.5
active	9602495	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	630.96	CHEMBL5455	Homo sapiens	pKi		6.2
inactive	9602496	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602497	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602498	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
inactive	9602499	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602500	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602501	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602502	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602503	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	501.19	CHEMBL5455	Homo sapiens	pKi		6.3
inactive	9602504	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602505	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602506	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602507	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602508	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602509	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602510	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602511	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602512	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602513	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	10.0	CHEMBL5455	Homo sapiens	pKi		8.0
inactive	9602514	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602515	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602516	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602517	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	=	Ki	nM	1584.89	CHEMBL5455	Homo sapiens	pKi		5.8
active	9602518	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9602519	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602520	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602521	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602522	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602523	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602524	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602525	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602526	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602527	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602528	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602529	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602530	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602531	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602532	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602533	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	316.23	CHEMBL5455	Homo sapiens	pKi		6.5
inactive	9602534	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602535	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	251.19	CHEMBL5455	Homo sapiens	pKi		6.6
active	9602536	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	1584.89	CHEMBL5455	Homo sapiens	pKi		5.8
inactive	9602537	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602538	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602539	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602540	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602541	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602542	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	316.23	CHEMBL5455	Homo sapiens	pKi		6.5
inactive	9602543	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602544	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602545	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602546	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602547	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602548	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602549	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602550	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602551	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602552	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602553	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602554	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602555	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602556	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602557	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602558	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602559	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	630.96	CHEMBL5455	Homo sapiens	pKi		6.2
inactive	9602560	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602561	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	630.96	CHEMBL5455	Homo sapiens	pKi		6.2
inactive	9602562	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602563	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
inactive	9602564	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602565	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602566	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602567	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602568	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602569	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	125.89	CHEMBL5455	Homo sapiens	pKi		6.9
inactive	9602570	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602571	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602572	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602573	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602574	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602575	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602576	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602577	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602578	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
inactive	9602579	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602580	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602581	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602582	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602583	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602584	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602585	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602586	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL5455	Homo sapiens	pKi		6.1
inactive	9602587	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602588	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602589	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602590	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602591	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602592	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602593	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9602594	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602595	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
inactive	9602596	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602597	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602598	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602599	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602600	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602601	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	19.95	CHEMBL5455	Homo sapiens	pKi		7.7
active	9602602	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602603	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602604	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602605	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602606	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602607	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602608	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602609	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602610	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602611	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602612	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	125.89	CHEMBL5455	Homo sapiens	pKi		6.9
inactive	9602613	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602614	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602615	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
active	9602616	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	1584.89	CHEMBL5455	Homo sapiens	pKi		5.8
inactive	9602617	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602618	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	50.12	CHEMBL5455	Homo sapiens	pKi		7.3
active	9602619	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	501.19	CHEMBL5455	Homo sapiens	pKi		6.3
active	9602620	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	79.43	CHEMBL5455	Homo sapiens	pKi		7.1
inactive	9602621	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602622	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602623	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602624	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602625	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602626	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602627	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602628	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	12.59	CHEMBL5455	Homo sapiens	pKi		7.9
inactive	9602629	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602630	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602631	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602632	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602633	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602634	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602635	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602636	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602637	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602638	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602639	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602640	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	501.19	CHEMBL5455	Homo sapiens	pKi		6.3
inactive	9602641	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602642	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602643	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602644	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602645	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602646	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602647	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602648	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602649	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602650	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602651	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602652	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602653	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	251.19	CHEMBL5455	Homo sapiens	pKi		6.6
inactive	9602654	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602655	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602656	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9602657	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1258.93	CHEMBL5455	Homo sapiens	pKi		5.9
inactive	9602658	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602659	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602660	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602661	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602662	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602663	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602664	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602665	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602666	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602667	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9602668	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606237	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
inactive	9606238	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606239	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606240	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606241	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606242	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	199.53	CHEMBL5455	Homo sapiens	pKi		6.7
inactive	9606243	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606244	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606245	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606246	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606247	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	794.33	CHEMBL5455	Homo sapiens	pKi		6.1
inactive	9606248	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606249	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606250	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606251	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606252	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	251.19	CHEMBL5455	Homo sapiens	pKi		6.6
inactive	9606253	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606254	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606255	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606256	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606257	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	1000.0	CHEMBL5455	Homo sapiens	pKi		6.0
active	9606258	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	316.23	CHEMBL5455	Homo sapiens	pKi		6.5
inactive	9606259	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606260	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606261	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606262	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606263	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606264	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606265	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	398.11	CHEMBL5455	Homo sapiens	pKi		6.4
inactive	9606266	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606267	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	158.49	CHEMBL5455	Homo sapiens	pKi		6.8
active	9606268	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	251.19	CHEMBL5455	Homo sapiens	pKi		6.6
inactive	9606269	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606270	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606271	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
active	9606272	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	1584.89	CHEMBL5455	Homo sapiens	pKi		5.8
active	9606273	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	10.0	CHEMBL5455	Homo sapiens	pKi		8.0
inactive	9606274	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606275	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606276	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606277	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
inactive	9606278	CHEMBL1963758	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FES	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	1995.26	CHEMBL5455	Homo sapiens	pKi		5.7
	10838581	CHEMBL2014154	Inhibition of FES at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	INH	%	4.0
	10867521	CHEMBL2027411	Inhibition of FES at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	10981540	CHEMBL2067606	Inhibition of human Fes at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL5455	Homo sapiens	INH	%	90.0
	10981555	CHEMBL2067591	Inhibition of human Fes	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	99.0	CHEMBL5455	Homo sapiens	IC50	nM	99.0
	12046303	CHEMBL2156633	Inhibition of Fes at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1	Outside typical range	CHEMBL2152768	=	Inhibition	%	-10.7	CHEMBL5455	Homo sapiens	INH	%	-10.7
	12074597	CHEMBL2160994	Inhibition of FES at 0.1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	12074607	CHEMBL2161004	Inhibition of FES at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	>	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	12094376	CHEMBL2166155	Inhibition of human FES at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	>	Inhibition	%	75.0	CHEMBL5455	Homo sapiens	INH	%	75.0
	12173615	CHEMBL2213992	Inhibition of FES assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	94.0	CHEMBL5455	Homo sapiens	Activity	%	94.0
	12183887	CHEMBL2211500	Inhibition of FES	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	pIC50		5.0
	12228319	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	125.0	CHEMBL5455	Homo sapiens	Residual Activity	%	125.0
	12228320	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	112.0	CHEMBL5455	Homo sapiens	Residual Activity	%	112.0
	12228321	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	113.0	CHEMBL5455	Homo sapiens	Residual Activity	%	113.0
	12228322	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	118.0	CHEMBL5455	Homo sapiens	Residual Activity	%	118.0
	12228323	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	116.0	CHEMBL5455	Homo sapiens	Residual Activity	%	116.0
	12228324	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	109.0	CHEMBL5455	Homo sapiens	Residual Activity	%	109.0
	12228325	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	40.0	CHEMBL5455	Homo sapiens	Residual Activity	%	40.0
	12228326	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	119.0	CHEMBL5455	Homo sapiens	Residual Activity	%	119.0
	12228327	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	134.0	CHEMBL5455	Homo sapiens	Residual Activity	%	134.0
	12228328	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	132.0	CHEMBL5455	Homo sapiens	Residual Activity	%	132.0
	12228329	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	118.0	CHEMBL5455	Homo sapiens	Residual Activity	%	118.0
	12228330	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	101.0	CHEMBL5455	Homo sapiens	Residual Activity	%	101.0
	12228331	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	115.0	CHEMBL5455	Homo sapiens	Residual Activity	%	115.0
	12228332	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	95.0	CHEMBL5455	Homo sapiens	Residual Activity	%	95.0
	12228333	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	32.0	CHEMBL5455	Homo sapiens	Residual Activity	%	32.0
	12228334	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	119.0	CHEMBL5455	Homo sapiens	Residual Activity	%	119.0
	12228335	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	121.0	CHEMBL5455	Homo sapiens	Residual Activity	%	121.0
	12228336	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	121.0	CHEMBL5455	Homo sapiens	Residual Activity	%	121.0
	12228337	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	123.0	CHEMBL5455	Homo sapiens	Residual Activity	%	123.0
	12228338	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	76.0	CHEMBL5455	Homo sapiens	Residual Activity	%	76.0
	12228339	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	104.0	CHEMBL5455	Homo sapiens	Residual Activity	%	104.0
	12228340	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	112.0	CHEMBL5455	Homo sapiens	Residual Activity	%	112.0
	12228341	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	113.0	CHEMBL5455	Homo sapiens	Residual Activity	%	113.0
	12228342	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	115.0	CHEMBL5455	Homo sapiens	Residual Activity	%	115.0
	12228343	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	124.0	CHEMBL5455	Homo sapiens	Residual Activity	%	124.0
	12228344	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	112.0	CHEMBL5455	Homo sapiens	Residual Activity	%	112.0
	12228345	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12228346	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	95.0	CHEMBL5455	Homo sapiens	Residual Activity	%	95.0
	12228347	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL5455	Homo sapiens	Residual Activity	%	98.0
	12228348	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	91.0	CHEMBL5455	Homo sapiens	Residual Activity	%	91.0
	12228349	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12228350	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	78.0	CHEMBL5455	Homo sapiens	Residual Activity	%	78.0
	12228351	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	120.0	CHEMBL5455	Homo sapiens	Residual Activity	%	120.0
	12228352	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	116.0	CHEMBL5455	Homo sapiens	Residual Activity	%	116.0
	12228353	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12228354	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12228355	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12228356	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	106.0	CHEMBL5455	Homo sapiens	Residual Activity	%	106.0
	12228357	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	111.0	CHEMBL5455	Homo sapiens	Residual Activity	%	111.0
	12228358	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12228359	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	129.0	CHEMBL5455	Homo sapiens	Residual Activity	%	129.0
	12228360	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	133.0	CHEMBL5455	Homo sapiens	Residual Activity	%	133.0
	12228361	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	32.0	CHEMBL5455	Homo sapiens	Residual Activity	%	32.0
	12228362	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	93.0	CHEMBL5455	Homo sapiens	Residual Activity	%	93.0
	12228363	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	79.0	CHEMBL5455	Homo sapiens	Residual Activity	%	79.0
	12228364	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	111.0	CHEMBL5455	Homo sapiens	Residual Activity	%	111.0
	12228365	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	115.0	CHEMBL5455	Homo sapiens	Residual Activity	%	115.0
	12228366	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	92.0	CHEMBL5455	Homo sapiens	Residual Activity	%	92.0
	12228367	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	139.0	CHEMBL5455	Homo sapiens	Residual Activity	%	139.0
	12228368	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	137.0	CHEMBL5455	Homo sapiens	Residual Activity	%	137.0
	12228369	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12228370	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	112.0	CHEMBL5455	Homo sapiens	Residual Activity	%	112.0
	12228371	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	62.0	CHEMBL5455	Homo sapiens	Residual Activity	%	62.0
	12228372	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	114.0	CHEMBL5455	Homo sapiens	Residual Activity	%	114.0
	12228373	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	124.0	CHEMBL5455	Homo sapiens	Residual Activity	%	124.0
	12228374	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	117.0	CHEMBL5455	Homo sapiens	Residual Activity	%	117.0
	12228375	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	129.0	CHEMBL5455	Homo sapiens	Residual Activity	%	129.0
	12228376	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	117.0	CHEMBL5455	Homo sapiens	Residual Activity	%	117.0
	12228377	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	111.0	CHEMBL5455	Homo sapiens	Residual Activity	%	111.0
	12228378	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	111.0	CHEMBL5455	Homo sapiens	Residual Activity	%	111.0
	12228379	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	101.0	CHEMBL5455	Homo sapiens	Residual Activity	%	101.0
	12228380	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	15.0	CHEMBL5455	Homo sapiens	Residual Activity	%	15.0
	12228381	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12228382	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	116.0	CHEMBL5455	Homo sapiens	Residual Activity	%	116.0
	12228383	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	125.0	CHEMBL5455	Homo sapiens	Residual Activity	%	125.0
	12228384	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	113.0	CHEMBL5455	Homo sapiens	Residual Activity	%	113.0
	12228385	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	111.0	CHEMBL5455	Homo sapiens	Residual Activity	%	111.0
	12228386	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	106.0	CHEMBL5455	Homo sapiens	Residual Activity	%	106.0
	12228387	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12228388	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12228389	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12228390	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	84.0	CHEMBL5455	Homo sapiens	Residual Activity	%	84.0
	12228391	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	125.0	CHEMBL5455	Homo sapiens	Residual Activity	%	125.0
	12228392	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	131.0	CHEMBL5455	Homo sapiens	Residual Activity	%	131.0
	12228393	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	123.0	CHEMBL5455	Homo sapiens	Residual Activity	%	123.0
	12228394	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	127.0	CHEMBL5455	Homo sapiens	Residual Activity	%	127.0
	12228395	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	128.0	CHEMBL5455	Homo sapiens	Residual Activity	%	128.0
	12228396	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	14.0	CHEMBL5455	Homo sapiens	Residual Activity	%	14.0
	12228397	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	126.0	CHEMBL5455	Homo sapiens	Residual Activity	%	126.0
	12228398	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL5455	Homo sapiens	Residual Activity	%	0.0
	12228399	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	106.0	CHEMBL5455	Homo sapiens	Residual Activity	%	106.0
	12228400	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	84.0	CHEMBL5455	Homo sapiens	Residual Activity	%	84.0
	12228401	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	100.0	CHEMBL5455	Homo sapiens	Residual Activity	%	100.0
	12228402	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12228403	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	82.0	CHEMBL5455	Homo sapiens	Residual Activity	%	82.0
	12228404	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12228405	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12231002	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	112.0	CHEMBL5455	Homo sapiens	Residual Activity	%	112.0
	12231003	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231004	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	72.0	CHEMBL5455	Homo sapiens	Residual Activity	%	72.0
	12231005	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231006	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	85.0	CHEMBL5455	Homo sapiens	Residual Activity	%	85.0
	12231007	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	58.0	CHEMBL5455	Homo sapiens	Residual Activity	%	58.0
	12231008	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231009	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	90.0	CHEMBL5455	Homo sapiens	Residual Activity	%	90.0
	12231010	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	109.0	CHEMBL5455	Homo sapiens	Residual Activity	%	109.0
	12231011	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231012	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231013	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231014	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL5455	Homo sapiens	Residual Activity	%	92.0
	12231015	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	79.0	CHEMBL5455	Homo sapiens	Residual Activity	%	79.0
	12231016	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	7.0	CHEMBL5455	Homo sapiens	Residual Activity	%	7.0
	12231017	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231018	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	90.0	CHEMBL5455	Homo sapiens	Residual Activity	%	90.0
	12231019	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	35.0	CHEMBL5455	Homo sapiens	Residual Activity	%	35.0
	12231020	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231021	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	104.0	CHEMBL5455	Homo sapiens	Residual Activity	%	104.0
	12231022	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231023	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12231024	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	63.0	CHEMBL5455	Homo sapiens	Residual Activity	%	63.0
	12231025	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	100.0	CHEMBL5455	Homo sapiens	Residual Activity	%	100.0
	12231026	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231027	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	16.0	CHEMBL5455	Homo sapiens	Residual Activity	%	16.0
	12231028	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL5455	Homo sapiens	Residual Activity	%	99.0
	12231029	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231030	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	93.0	CHEMBL5455	Homo sapiens	Residual Activity	%	93.0
	12231031	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	78.0	CHEMBL5455	Homo sapiens	Residual Activity	%	78.0
	12231032	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12231033	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	106.0	CHEMBL5455	Homo sapiens	Residual Activity	%	106.0
	12231034	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	103.0	CHEMBL5455	Homo sapiens	Residual Activity	%	103.0
	12231035	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	35.0	CHEMBL5455	Homo sapiens	Residual Activity	%	35.0
	12231036	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	55.0	CHEMBL5455	Homo sapiens	Residual Activity	%	55.0
	12231037	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	58.0	CHEMBL5455	Homo sapiens	Residual Activity	%	58.0
	12231038	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	88.0	CHEMBL5455	Homo sapiens	Residual Activity	%	88.0
	12231039	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	71.0	CHEMBL5455	Homo sapiens	Residual Activity	%	71.0
	12231040	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231041	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	79.0	CHEMBL5455	Homo sapiens	Residual Activity	%	79.0
	12231042	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	106.0	CHEMBL5455	Homo sapiens	Residual Activity	%	106.0
	12231043	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	34.0	CHEMBL5455	Homo sapiens	Residual Activity	%	34.0
	12231044	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL5455	Homo sapiens	Residual Activity	%	2.0
	12231045	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	62.0	CHEMBL5455	Homo sapiens	Residual Activity	%	62.0
	12231046	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	84.0	CHEMBL5455	Homo sapiens	Residual Activity	%	84.0
	12231047	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	34.0	CHEMBL5455	Homo sapiens	Residual Activity	%	34.0
	12231048	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	83.0	CHEMBL5455	Homo sapiens	Residual Activity	%	83.0
	12231049	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	13.0	CHEMBL5455	Homo sapiens	Residual Activity	%	13.0
	12231050	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	57.0	CHEMBL5455	Homo sapiens	Residual Activity	%	57.0
	12231051	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	95.0	CHEMBL5455	Homo sapiens	Residual Activity	%	95.0
	12231052	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	61.0	CHEMBL5455	Homo sapiens	Residual Activity	%	61.0
	12231053	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	79.0	CHEMBL5455	Homo sapiens	Residual Activity	%	79.0
	12231054	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	98.0	CHEMBL5455	Homo sapiens	Residual Activity	%	98.0
	12231055	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	93.0	CHEMBL5455	Homo sapiens	Residual Activity	%	93.0
	12231056	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	75.0	CHEMBL5455	Homo sapiens	Residual Activity	%	75.0
	12231057	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	98.0	CHEMBL5455	Homo sapiens	Residual Activity	%	98.0
	12231058	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231059	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231060	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	109.0	CHEMBL5455	Homo sapiens	Residual Activity	%	109.0
	12231061	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12231062	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12231063	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	98.0	CHEMBL5455	Homo sapiens	Residual Activity	%	98.0
	12231064	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	109.0	CHEMBL5455	Homo sapiens	Residual Activity	%	109.0
	12231065	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	105.0	CHEMBL5455	Homo sapiens	Residual Activity	%	105.0
	12231066	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231067	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12231068	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12231069	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231070	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	91.0	CHEMBL5455	Homo sapiens	Residual Activity	%	91.0
	12231071	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12231072	CHEMBL2219072	Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	19.0	CHEMBL5455	Homo sapiens	Residual Activity	%	19.0
	12231073	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	98.0	CHEMBL5455	Homo sapiens	Residual Activity	%	98.0
	12231074	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	48.0	CHEMBL5455	Homo sapiens	Residual Activity	%	48.0
	12231075	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231076	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231077	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	92.0	CHEMBL5455	Homo sapiens	Residual Activity	%	92.0
	12231078	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231079	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	15.0	CHEMBL5455	Homo sapiens	Residual Activity	%	15.0
	12231080	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231081	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	88.0	CHEMBL5455	Homo sapiens	Residual Activity	%	88.0
	12231082	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	83.0	CHEMBL5455	Homo sapiens	Residual Activity	%	83.0
	12231083	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	81.0	CHEMBL5455	Homo sapiens	Residual Activity	%	81.0
	12231084	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	74.0	CHEMBL5455	Homo sapiens	Residual Activity	%	74.0
	12231085	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	78.0	CHEMBL5455	Homo sapiens	Residual Activity	%	78.0
	12231086	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	27.0	CHEMBL5455	Homo sapiens	Residual Activity	%	27.0
	12231087	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	3.0	CHEMBL5455	Homo sapiens	Residual Activity	%	3.0
	12231088	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	80.0	CHEMBL5455	Homo sapiens	Residual Activity	%	80.0
	12231089	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	105.0	CHEMBL5455	Homo sapiens	Residual Activity	%	105.0
	12231090	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	76.0	CHEMBL5455	Homo sapiens	Residual Activity	%	76.0
	12231091	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	83.0	CHEMBL5455	Homo sapiens	Residual Activity	%	83.0
	12231092	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	52.0	CHEMBL5455	Homo sapiens	Residual Activity	%	52.0
	12231093	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL5455	Homo sapiens	Residual Activity	%	81.0
	12231094	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	69.0	CHEMBL5455	Homo sapiens	Residual Activity	%	69.0
	12231095	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	77.0	CHEMBL5455	Homo sapiens	Residual Activity	%	77.0
	12231096	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231097	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12231098	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	80.0	CHEMBL5455	Homo sapiens	Residual Activity	%	80.0
	12231099	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	28.0	CHEMBL5455	Homo sapiens	Residual Activity	%	28.0
	12231100	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	65.0	CHEMBL5455	Homo sapiens	Residual Activity	%	65.0
	12231101	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231102	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	48.0	CHEMBL5455	Homo sapiens	Residual Activity	%	48.0
	12231103	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	80.0	CHEMBL5455	Homo sapiens	Residual Activity	%	80.0
	12231104	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	46.0	CHEMBL5455	Homo sapiens	Residual Activity	%	46.0
	12231105	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231106	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL5455	Homo sapiens	Residual Activity	%	98.0
	12231107	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231108	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231109	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	59.0	CHEMBL5455	Homo sapiens	Residual Activity	%	59.0
	12231110	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	84.0	CHEMBL5455	Homo sapiens	Residual Activity	%	84.0
	12231111	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231112	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	78.0	CHEMBL5455	Homo sapiens	Residual Activity	%	78.0
	12231113	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	88.0	CHEMBL5455	Homo sapiens	Residual Activity	%	88.0
	12231114	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231115	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	28.0	CHEMBL5455	Homo sapiens	Residual Activity	%	28.0
	12231116	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	20.0	CHEMBL5455	Homo sapiens	Residual Activity	%	20.0
	12231117	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	36.0	CHEMBL5455	Homo sapiens	Residual Activity	%	36.0
	12231118	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	72.0	CHEMBL5455	Homo sapiens	Residual Activity	%	72.0
	12231119	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	83.0	CHEMBL5455	Homo sapiens	Residual Activity	%	83.0
	12231120	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	44.0	CHEMBL5455	Homo sapiens	Residual Activity	%	44.0
	12231121	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231122	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231123	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	26.0	CHEMBL5455	Homo sapiens	Residual Activity	%	26.0
	12231124	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	52.0	CHEMBL5455	Homo sapiens	Residual Activity	%	52.0
	12231125	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	15.0	CHEMBL5455	Homo sapiens	Residual Activity	%	15.0
	12231126	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	47.0	CHEMBL5455	Homo sapiens	Residual Activity	%	47.0
	12231127	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	76.0	CHEMBL5455	Homo sapiens	Residual Activity	%	76.0
	12231128	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	82.0	CHEMBL5455	Homo sapiens	Residual Activity	%	82.0
	12231129	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	90.0	CHEMBL5455	Homo sapiens	Residual Activity	%	90.0
	12231130	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	93.0	CHEMBL5455	Homo sapiens	Residual Activity	%	93.0
	12231131	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	75.0	CHEMBL5455	Homo sapiens	Residual Activity	%	75.0
	12231132	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231133	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	68.0	CHEMBL5455	Homo sapiens	Residual Activity	%	68.0
	12231134	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	9.0	CHEMBL5455	Homo sapiens	Residual Activity	%	9.0
	12231135	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	91.0	CHEMBL5455	Homo sapiens	Residual Activity	%	91.0
	12231136	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL5455	Homo sapiens	Residual Activity	%	93.0
	12231137	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	99.0	CHEMBL5455	Homo sapiens	Residual Activity	%	99.0
	12231138	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	79.0	CHEMBL5455	Homo sapiens	Residual Activity	%	79.0
	12231139	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12231140	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231141	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	85.0	CHEMBL5455	Homo sapiens	Residual Activity	%	85.0
	12231142	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	90.0	CHEMBL5455	Homo sapiens	Residual Activity	%	90.0
	12231143	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	93.0	CHEMBL5455	Homo sapiens	Residual Activity	%	93.0
	12231144	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	68.0	CHEMBL5455	Homo sapiens	Residual Activity	%	68.0
	12231145	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	14.0	CHEMBL5455	Homo sapiens	Residual Activity	%	14.0
	12231146	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231147	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	59.0	CHEMBL5455	Homo sapiens	Residual Activity	%	59.0
	12231148	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	82.0	CHEMBL5455	Homo sapiens	Residual Activity	%	82.0
	12231149	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	90.0	CHEMBL5455	Homo sapiens	Residual Activity	%	90.0
	12231150	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL5455	Homo sapiens	Residual Activity	%	2.0
	12231151	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231152	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL5455	Homo sapiens	Residual Activity	%	0.0
	12231153	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL5455	Homo sapiens	Residual Activity	%	101.0
	12231154	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	27.0	CHEMBL5455	Homo sapiens	Residual Activity	%	27.0
	12231155	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12231156	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231157	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	61.0	CHEMBL5455	Homo sapiens	Residual Activity	%	61.0
	12231158	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL5455	Homo sapiens	Residual Activity	%	100.0
	12231159	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231160	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL5455	Homo sapiens	Residual Activity	%	105.0
	12231161	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL5455	Homo sapiens	Residual Activity	%	96.0
	12231162	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	30.0	CHEMBL5455	Homo sapiens	Residual Activity	%	30.0
	12231163	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	103.0	CHEMBL5455	Homo sapiens	Residual Activity	%	103.0
	12231164	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231165	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	21.0	CHEMBL5455	Homo sapiens	Residual Activity	%	21.0
	12231166	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL5455	Homo sapiens	Residual Activity	%	106.0
	12231167	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL5455	Homo sapiens	Residual Activity	%	102.0
	12231168	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	101.0	CHEMBL5455	Homo sapiens	Residual Activity	%	101.0
	12231169	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	117.0	CHEMBL5455	Homo sapiens	Residual Activity	%	117.0
	12231170	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231171	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	104.0	CHEMBL5455	Homo sapiens	Residual Activity	%	104.0
	12231172	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	108.0	CHEMBL5455	Homo sapiens	Residual Activity	%	108.0
	12231173	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	56.0	CHEMBL5455	Homo sapiens	Residual Activity	%	56.0
	12231174	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL5455	Homo sapiens	Residual Activity	%	1.0
	12231175	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	107.0	CHEMBL5455	Homo sapiens	Residual Activity	%	107.0
	12231176	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	99.0	CHEMBL5455	Homo sapiens	Residual Activity	%	99.0
	12231177	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	43.0	CHEMBL5455	Homo sapiens	Residual Activity	%	43.0
	12231178	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	51.0	CHEMBL5455	Homo sapiens	Residual Activity	%	51.0
	12231179	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	104.0	CHEMBL5455	Homo sapiens	Residual Activity	%	104.0
	12231180	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	88.0	CHEMBL5455	Homo sapiens	Residual Activity	%	88.0
	12231181	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	92.0	CHEMBL5455	Homo sapiens	Residual Activity	%	92.0
	12231182	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	38.0	CHEMBL5455	Homo sapiens	Residual Activity	%	38.0
	12231183	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	116.0	CHEMBL5455	Homo sapiens	Residual Activity	%	116.0
	12231184	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	120.0	CHEMBL5455	Homo sapiens	Residual Activity	%	120.0
	12231185	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	5.0	CHEMBL5455	Homo sapiens	Residual Activity	%	5.0
	12231186	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	78.0	CHEMBL5455	Homo sapiens	Residual Activity	%	78.0
	12231187	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231188	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL5455	Homo sapiens	Residual Activity	%	85.0
	12231189	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	24.0	CHEMBL5455	Homo sapiens	Residual Activity	%	24.0
	12231190	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231191	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	91.0	CHEMBL5455	Homo sapiens	Residual Activity	%	91.0
	12231192	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	111.0	CHEMBL5455	Homo sapiens	Residual Activity	%	111.0
	12231193	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	12.0	CHEMBL5455	Homo sapiens	Residual Activity	%	12.0
	12231194	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	9.0	CHEMBL5455	Homo sapiens	Residual Activity	%	9.0
	12231195	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	12.0	CHEMBL5455	Homo sapiens	Residual Activity	%	12.0
	12231196	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	92.0	CHEMBL5455	Homo sapiens	Residual Activity	%	92.0
	12231197	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	48.0	CHEMBL5455	Homo sapiens	Residual Activity	%	48.0
	12231198	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231199	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	19.0	CHEMBL5455	Homo sapiens	Residual Activity	%	19.0
	12231200	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	95.0	CHEMBL5455	Homo sapiens	Residual Activity	%	95.0
	12231201	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	51.0	CHEMBL5455	Homo sapiens	Residual Activity	%	51.0
	12231202	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL5455	Homo sapiens	Residual Activity	%	1.0
	12231203	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	23.0	CHEMBL5455	Homo sapiens	Residual Activity	%	23.0
	12231204	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	89.0	CHEMBL5455	Homo sapiens	Residual Activity	%	89.0
	12231205	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	6.0	CHEMBL5455	Homo sapiens	Residual Activity	%	6.0
	12231206	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231207	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	1.0	CHEMBL5455	Homo sapiens	Residual Activity	%	1.0
	12231208	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	12.0	CHEMBL5455	Homo sapiens	Residual Activity	%	12.0
	12231209	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231210	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	9.0	CHEMBL5455	Homo sapiens	Residual Activity	%	9.0
	12231211	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	100.0	CHEMBL5455	Homo sapiens	Residual Activity	%	100.0
	12231212	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	94.0	CHEMBL5455	Homo sapiens	Residual Activity	%	94.0
	12231213	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	100.0	CHEMBL5455	Homo sapiens	Residual Activity	%	100.0
	12231214	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	27.0	CHEMBL5455	Homo sapiens	Residual Activity	%	27.0
	12231215	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	71.0	CHEMBL5455	Homo sapiens	Residual Activity	%	71.0
	12231216	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	31.0	CHEMBL5455	Homo sapiens	Residual Activity	%	31.0
	12231217	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	101.0	CHEMBL5455	Homo sapiens	Residual Activity	%	101.0
	12231218	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231219	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	97.0	CHEMBL5455	Homo sapiens	Residual Activity	%	97.0
	12231220	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	73.0	CHEMBL5455	Homo sapiens	Residual Activity	%	73.0
	12231221	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	86.0	CHEMBL5455	Homo sapiens	Residual Activity	%	86.0
	12231222	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL5455	Homo sapiens	Residual Activity	%	105.0
	12231223	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	70.0	CHEMBL5455	Homo sapiens	Residual Activity	%	70.0
	12231224	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	74.0	CHEMBL5455	Homo sapiens	Residual Activity	%	74.0
	12231225	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	92.0	CHEMBL5455	Homo sapiens	Residual Activity	%	92.0
	12231226	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	101.0	CHEMBL5455	Homo sapiens	Residual Activity	%	101.0
	12231227	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	95.0	CHEMBL5455	Homo sapiens	Residual Activity	%	95.0
	12231228	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	87.0	CHEMBL5455	Homo sapiens	Residual Activity	%	87.0
	12231229	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	99.0	CHEMBL5455	Homo sapiens	Residual Activity	%	99.0
	12231230	CHEMBL2219073	Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	12.0	CHEMBL5455	Homo sapiens	Residual Activity	%	12.0
	12626690	CHEMBL2317137	Inhibition of FES (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL5455	Homo sapiens	INH	%	80.0
	12650030	CHEMBL2327557	Inhibition of FES (unknown origin) relative to control	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	=	Inhibition	%	60.0	CHEMBL5455	Homo sapiens	INH	%	60.0
	12693236	CHEMBL2343920	Inhibition of FES (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	nM	10000.0
	12728830	CHEMBL2352903	Inhibition of FES (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	92.0	CHEMBL5455	Homo sapiens	Activity	%	92.0
	12729075	CHEMBL2352253	Inhibition of FES (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL5455	Homo sapiens	Activity	%	97.0
	12729962	CHEMBL2352197	Inhibition of Fes (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	78.0	CHEMBL5455	Homo sapiens	Activity	%	78.0
	12730218	CHEMBL2352903	Inhibition of FES (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL5455	Homo sapiens	Activity	%	99.0
	13375867	CHEMBL2405129	Inhibition of FES (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL5455	Homo sapiens	INH	%	4.0
	13442360	CHEMBL2427792	Competitive binding affinity to FES (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	13445495	CHEMBL2427792	Competitive binding affinity to FES (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	13448550	CHEMBL2427792	Competitive binding affinity to FES (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	13448686	CHEMBL2427792	Competitive binding affinity to FES (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	13451481	CHEMBL2427792	Competitive binding affinity to FES (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	13454666	CHEMBL2427792	Competitive binding affinity to FES (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	13872148	CHEMBL3101773	Inhibition of human Fes assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	107.0	CHEMBL5455	Homo sapiens	Activity	%	107.0
Not Active	13898467	CHEMBL3110512	Inhibition of FES (unknown origin) SH3 domain expressed in HEK293 cells at 500 nM preincubated for 1 hr followed by compound washout measured after 30 mins by qPCR analysis	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108909		Inhibition	%		CHEMBL5455	Homo sapiens	INH		
	13941193	CHEMBL3129258	Inhibition of FES (unknown origin) using Km levels of ATP	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	5.0	CHEMBL5455	Homo sapiens	IC50	nM	5.0
	13953326	CHEMBL3130923	Inhibition of human FES assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	92.0	CHEMBL5455	Homo sapiens	Activity	%	92.0
	13953327	CHEMBL3130923	Inhibition of human FES assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	92.0	CHEMBL5455	Homo sapiens	Activity	%	92.0
	13954712	CHEMBL3130923	Inhibition of human FES assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	85.0	CHEMBL5455	Homo sapiens	Activity	%	85.0
	14582502	CHEMBL3242354	Inhibition of human Fes assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	92.0	CHEMBL5455	Homo sapiens	Activity	%	92.0
	14722520	CHEMBL3293404	Inhibition of FES (unknown origin) by TR-FRET-based Z'-LYTE assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	6.0	CHEMBL5455	Homo sapiens	IC50	nM	6.0
	15018591	CHEMBL3362255	Inhibition of FES (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	-2.3	CHEMBL5455	Homo sapiens	INH	%	-2.3
	15736001	CHEMBL3625839	Inhibition of human recombinant Fes	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	uM	10.0
	15756988	CHEMBL3630495	Inhibition of FES (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	33.81	CHEMBL5455	Homo sapiens	INH	%	33.81
	15757735	CHEMBL3630495	Inhibition of FES (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	42.43	CHEMBL5455	Homo sapiens	INH	%	42.43
	15758714	CHEMBL3630495	Inhibition of FES (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	16.44	CHEMBL5455	Homo sapiens	INH	%	16.44
	16413447	CHEMBL3743697	Inhibition of FES (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	uM	10.0
	16425349	CHEMBL3751243	Inhibition of Fes (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	7.2	CHEMBL5455	Homo sapiens	INH	%	7.2
	16431831	CHEMBL3748185	Inhibition of human FES using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	uM	10.0
	16450847	CHEMBL3762703	Inhibition of FES (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	6.0	CHEMBL5455	Homo sapiens	INH	%	6.0
	16495990	CHEMBL3778581	Inhibition of FES (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	2.0	CHEMBL5455	Homo sapiens	Activity	%	2.0
	16508177	CHEMBL3778581	Inhibition of FES (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-1.0	CHEMBL5455	Homo sapiens	Activity	%	-1.0
	16509154	CHEMBL3778581	Inhibition of FES (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-15.0	CHEMBL5455	Homo sapiens	Activity	%	-15.0
	16593490	CHEMBL3812173	Inhibition of His-tagged full length human recombinant FES expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL5455	Homo sapiens	INH	%	40.0
	16614474	CHEMBL3816604	Inhibition of human FES at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-13.0	CHEMBL5455	Homo sapiens	INH	%	-13.0
	16618215	CHEMBL3816339	Inhibition of full length recombinant human His-tagged cytoplasmic FES expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	16621494	CHEMBL3820487	Inhibition of FES (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL5455	Homo sapiens	IC50	nM	30000.0
	16622209	CHEMBL3820487	Inhibition of FES (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.1	CHEMBL5455	Homo sapiens	IC50	nM	8.1
	16737935	CHEMBL3856652	Inhibition of recombinant human FES expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	78.0	CHEMBL5455	Homo sapiens	Activity	%	78.0
	16804204	CHEMBL3869792	Inhibition of human recombinant full length His-tagged FES cytoplasmic domain expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	62.0	CHEMBL5455	Homo sapiens	INH	%	62.0
412019	17776734	CHEMBL3888663	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	nM	10000.0
Active	17902912	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	127.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	127.0
Inactive	17902913	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902914	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902915	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902916	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902917	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902918	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902919	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902920	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902921	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902922	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902923	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902924	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902925	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902926	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902927	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902928	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902929	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17902930	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	1769.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	1769.0
Inactive	17902931	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902932	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902933	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902934	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902935	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902936	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902937	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902938	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17902939	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	1122.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	1122.0
Inactive	17902940	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902941	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902942	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902943	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902944	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902945	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902946	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902947	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902948	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902949	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902950	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902951	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902952	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902953	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902954	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902955	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17902956	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Kd	nM	1742.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	1742.0
Inactive	17902957	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902958	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902959	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902960	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902961	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902962	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902963	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902964	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902965	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902966	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902967	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902968	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902969	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902970	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902971	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902972	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902973	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902974	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902975	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902976	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902977	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902978	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902979	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902980	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902981	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902982	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902983	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902984	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902985	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902986	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17902987	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	179.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	179.0
Inactive	17902988	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902989	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902990	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902991	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902992	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902993	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902994	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902995	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17902996	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	672.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	672.0
Inactive	17902997	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902998	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17902999	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903000	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903001	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903002	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903003	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903004	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903005	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903006	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903007	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903008	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903009	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903010	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903011	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903012	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903013	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903014	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903015	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903016	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903017	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903018	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903019	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17903020	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1234.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	1234.0
Inactive	17903021	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903022	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903023	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903024	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903025	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903026	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903027	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903028	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903029	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903030	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903031	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903032	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903033	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903034	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903035	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903036	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903037	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903038	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903039	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903040	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903041	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903042	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903043	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903044	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903045	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903046	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903047	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903048	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903049	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903050	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903051	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903052	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903053	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903054	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903055	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903056	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903057	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903058	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903059	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17903060	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1186.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	1186.0
Inactive	17903061	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903062	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903063	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903064	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903065	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903066	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903067	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903068	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903069	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903070	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903071	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903072	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903073	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903074	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903075	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903076	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903077	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17903078	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	319.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	319.0
Inactive	17903079	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903080	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903081	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903082	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903083	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903084	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903085	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903086	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903087	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903088	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903089	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903090	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903091	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903092	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903093	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903094	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903095	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903096	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903097	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903098	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903099	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903100	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903101	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903102	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903103	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903104	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903105	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903106	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903107	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903108	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17903109	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	594.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	594.0
Inactive	17903110	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903111	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903112	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903113	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17903114	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	2314.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	2314.0
Inactive	17903115	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903116	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903117	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903118	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903119	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903120	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903121	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903122	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903123	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903124	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903125	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903126	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903127	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903128	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903129	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903130	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903131	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903132	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903133	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903134	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903135	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903136	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903137	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903138	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903139	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903140	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903141	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903142	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903143	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903144	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903145	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903146	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903147	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903148	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903149	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Active	17903150	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	=	Kd	nM	1194.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	1194.0
Inactive	17903151	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903152	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903153	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903154	CHEMBL3991716	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5455	Homo sapiens	Kd apparent	nM	30000.0
	18052953	CHEMBL4011858	Inhibition of FES (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O	Outside typical range	CHEMBL4089159	=	Inhibition	%	-10.6	CHEMBL5455	Homo sapiens	INH	%	-10.6
	18114356	CHEMBL4025138	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	84.0	CHEMBL5455	Homo sapiens	Activity	%	84.0
	18203662	CHEMBL4043949	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	40.0	CHEMBL5455	Homo sapiens	Activity	%	40.0
	18211627	CHEMBL4045678	Inhibition of FES activation Loop (LRADNTLVAVKSCR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-30.2	CHEMBL5455	Homo sapiens	INH	%	-30.2
	18211825	CHEMBL4045921	Inhibition of FES activation Loop (LRADNTLVAVKSCR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-27.0	CHEMBL5455	Homo sapiens	INH	%	-27.0
	18248591	CHEMBL4053874	Inhibition of FES (FPS) (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	42.0	CHEMBL5455	Homo sapiens	INH	%	42.0
	18253811	CHEMBL4055190	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	18253812	CHEMBL4055190	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	98.0	CHEMBL5455	Homo sapiens	Activity	%	98.0
	18265786	CHEMBL4057236	Inhibition of FES (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-3.3	CHEMBL5455	Homo sapiens	INH	%	-3.3
	18266046	CHEMBL4057496	Inhibition of FES (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-5.3	CHEMBL5455	Homo sapiens	INH	%	-5.3
	18274887	CHEMBL4118341	Inhibition of FES in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled LRADNTLVAVKSCR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	77.3	CHEMBL5455	Homo sapiens	INH	%	77.3
	18274888	CHEMBL4118341	Inhibition of FES in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled LRADNTLVAVKSCR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	13.6	CHEMBL5455	Homo sapiens	INH	%	13.6
	18274889	CHEMBL4118341	Inhibition of FES in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled LRADNTLVAVKSCR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	67.7	CHEMBL5455	Homo sapiens	INH	%	67.7
	18282098	CHEMBL4120053	Inhibition of recombinant full length His-tagged human FES cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	17.1	CHEMBL5455	Homo sapiens	INH	%	17.1
	18282417	CHEMBL4120053	Inhibition of recombinant full length His-tagged human FES cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	21.1	CHEMBL5455	Homo sapiens	INH	%	21.1
	18282763	CHEMBL4120348	Inhibition of FES (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-3.3	CHEMBL5455	Homo sapiens	INH	%	-3.3
	18282990	CHEMBL4120575	Inhibition of FES (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-5.0	CHEMBL5455	Homo sapiens	INH	%	-5.0
	18283214	CHEMBL4120799	Inhibition of FES (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	11.7	CHEMBL5455	Homo sapiens	INH	%	11.7
	18440204	CHEMBL4157028	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL5455	Homo sapiens	Activity	%	98.0
	18463748	CHEMBL4181164	Inhibition of recombinant human full length N-terminal His6-tagged FES expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-8.0	CHEMBL5455	Homo sapiens	INH	%	-8.0
	18484644	CHEMBL4185807	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL5455	Homo sapiens	Activity	%	99.0
	18484981	CHEMBL4185807	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	90.0	CHEMBL5455	Homo sapiens	Activity	%	90.0
	18507793	CHEMBL4190969	Inhibition of recombinant human FES (2 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-5.0	CHEMBL5455	Homo sapiens	INH	%	-5.0
	18653639	CHEMBL4230084	Inhibition of FES (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	21.0	CHEMBL5455	Homo sapiens	INH	%	21.0
	18653640	CHEMBL4230084	Inhibition of FES (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	18655528	CHEMBL4230707	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	85.0	CHEMBL5455	Homo sapiens	Activity	%	85.0
	18674661	CHEMBL4235354	Inhibition of FES (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL5455	Homo sapiens	Ki	nM	2000.0
Not Determined	18674662	CHEMBL4235354	Inhibition of FES (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL5455	Homo sapiens	Ki		
	18674663	CHEMBL4235354	Inhibition of FES (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL5455	Homo sapiens	Ki	nM	10000.0
	18751112	CHEMBL4263802	Inhibition of FES (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-1.0	CHEMBL5455	Homo sapiens	INH	%	-1.0
	18751607	CHEMBL4264296	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	99.0	CHEMBL5455	Homo sapiens	Activity	%	99.0
	18761483	CHEMBL4266561	Inhibition of recombinant human N-terminal His6-tagged full length FES expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	11.0	CHEMBL5455	Homo sapiens	INH	%	11.0
	18761779	CHEMBL4266561	Inhibition of recombinant human N-terminal His6-tagged full length FES expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	42.0	CHEMBL5455	Homo sapiens	INH	%	42.0
	18761942	CHEMBL4266561	Inhibition of recombinant human N-terminal His6-tagged full length FES expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	18.0	CHEMBL5455	Homo sapiens	INH	%	18.0
	18849496	CHEMBL4305562	Inhibition of recombinant N-terminal GST fusion protein tagged human full length FES (1 to 413/416 to 822 residues) expressed in baculovirus expression system assessed as decrease in fluorescence labelled Srctide phosphorylation at 200 nM by off-chip mobility shift assay relative to control	B	Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(C#N)c3cn[nH]c(=O)c23)c1		CHEMBL4461851	>	Inhibition	%	90.0	CHEMBL5455	Homo sapiens	INH	%	90.0
	18857965	CHEMBL4307811	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	18892614	CHEMBL4314687	Inhibition of recombinant human FES (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.5	CHEMBL5455	Homo sapiens	Activity	%	100.5
	18919477	CHEMBL4322833	Binding affinity to recombinant full-length N-terminal His-tagged FES (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	106.0	CHEMBL5455	Homo sapiens	Kd	nM	106.0
	18919665	CHEMBL4322833	Binding affinity to recombinant full-length N-terminal His-tagged FES (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	114.0	CHEMBL5455	Homo sapiens	Kd	nM	114.0
	18937927	CHEMBL4327695	Inhibition of human FES assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	103.25	CHEMBL5455	Homo sapiens	Activity	%	103.25
	18937928	CHEMBL4327695	Inhibition of human FES assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.25	CHEMBL5455	Homo sapiens	Activity	%	98.25
	18938534	CHEMBL4328054	Inhibition of human FES assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5455	Homo sapiens	Activity	%	65.0
	18938912	CHEMBL4328418	Inhibition of human FES using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.52	CHEMBL5455	Homo sapiens	IC50	10'-9M	1.52
	18958882	CHEMBL4333401	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	98.0	CHEMBL5455	Homo sapiens	Activity	%	98.0
	18964287	CHEMBL4335081	Inhibition of recombinant human FES (2 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL5455	Homo sapiens	Activity	%	103.0
	18964288	CHEMBL4335081	Inhibition of recombinant human FES (2 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	91.0	CHEMBL5455	Homo sapiens	Activity	%	91.0
	18971898	CHEMBL4336908	Inhibition of recombinant human FES (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	41.0	CHEMBL5455	Homo sapiens	Activity	%	41.0
Not Active	19039783	CHEMBL4351859	Inhibition of recombinant human FES (2 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5455	Homo sapiens	INH		
Active	19041110	CHEMBL4352371	Inhibition of human FES at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5455	Homo sapiens	INH		
	19048769	CHEMBL4354254	Inhibition of FES (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	-1.0	CHEMBL5455	Homo sapiens	INH	%	-1.0
	19059584	CHEMBL4357885	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	19067241	CHEMBL4360630	Inhibition of FES (unknown origin)	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	569.0	CHEMBL5455	Homo sapiens	IC50	nmol/L	569.0
	19067245	CHEMBL4360630	Inhibition of FES (unknown origin)	B	COc1cc(N2CCC(O)CC2)ccc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2cn[nH]c2n1		CHEMBL4474361	=	IC50	nM	494.0	CHEMBL5455	Homo sapiens	IC50	nmol/L	494.0
	19067249	CHEMBL4360630	Inhibition of FES (unknown origin)	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4125960	=	IC50	nM	527.0	CHEMBL5455	Homo sapiens	IC50	nmol/L	527.0
	19090155	CHEMBL4365729	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	96.0	CHEMBL5455	Homo sapiens	Activity	%	96.0
	19091927	CHEMBL4366401	Inhibition of human FES at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-11.67	CHEMBL5455	Homo sapiens	INH	%	-11.67
	19092270	CHEMBL4366690	Inhibition of FES (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	10.0	CHEMBL5455	Homo sapiens	INH	%	10.0
	19140815	CHEMBL4376579	Inhibition of recombinant human His-tagged FES expressed in baculovirus system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	19144797	CHEMBL4377813	Inhibition of recombinant human FES (2 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	7.0	CHEMBL5455	Homo sapiens	INH	%	7.0
	19146914	CHEMBL4378878	Inhibition of recombinant human FES (2 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	0.0	CHEMBL5455	Homo sapiens	INH	%	0.0
	19147849	CHEMBL4379323	Inhibition of recombinant human FES (2 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5455	Homo sapiens	IC50	uM	10.0
	19159412	CHEMBL4382516	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	1.4	CHEMBL5455	Homo sapiens	Activity	%	1.4
	19181033	CHEMBL4387244	Inhibition of recombinant full length human His-tagged FES (FPS) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	11.0	CHEMBL5455	Homo sapiens	INH	%	11.0
	19181259	CHEMBL4387244	Inhibition of recombinant full length human His-tagged FES (FPS) expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	19.0	CHEMBL5455	Homo sapiens	INH	%	19.0
	19191595	CHEMBL4389235	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	99.0	CHEMBL5455	Homo sapiens	INH	%	99.0
	19191898	CHEMBL4389712	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5455	Homo sapiens	INH	%	100.0
	19199884	CHEMBL4391338	Binding affinity to wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	92.0	CHEMBL5455	Homo sapiens	Activity	%	92.0
	19266423	CHEMBL4405373	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	19275960	CHEMBL4407963	Inhibition of recombinant human FES (2 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	89.0	CHEMBL5455	Homo sapiens	INH	%	89.0
	20600527	CHEMBL4603479	Inhibition of recombinant His-tagged full length human FES expressed in baculovirus expression system using Tyr 01 peptide as substrate after 1 hr by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5455	Homo sapiens	IC50	uM	100.0
	22392057	CHEMBL4667152	Inhibition of recombinant human His-tagged full length FES expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	5.5	CHEMBL5455	Homo sapiens	INH	%	5.5
	22423100	CHEMBL4674115	Inhibition of human FES using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL5455	Homo sapiens	INH	%	80.0
	22423615	CHEMBL4674383	Inhibition of human FES using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	91.04	CHEMBL5455	Homo sapiens	Activity	%	91.04
	22423616	CHEMBL4674383	Inhibition of human FES using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	42.15	CHEMBL5455	Homo sapiens	Activity	%	42.15
	22427502	CHEMBL4675413	Inhibition of FES (unknown origin) at 1 uM relative to control	B	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1		CHEMBL4778548	>	Inhibition	%	90.0	CHEMBL5455	Homo sapiens	INH	%	90.0
	22427503	CHEMBL4675413	Inhibition of FES (unknown origin) at 1 uM relative to control	B	COc1cc(C(=O)NCCOCCOCCOCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1		CHEMBL4781145	>	Inhibition	%	90.0	CHEMBL5455	Homo sapiens	INH	%	90.0
	22818103	CHEMBL4715326	Inhibition of recombinant human N-terminal His6-tagged FES (561 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using poly (Glu,Tyr) (4:1) as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL5455	Homo sapiens	INH	%	50.0
	22843746	CHEMBL4720732	Inhibition of human FES using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.08	CHEMBL5455	Homo sapiens	IC50	10^-9M	2.08
	22844098	CHEMBL4721084	Inhibition of human FES assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	100.79	CHEMBL5455	Homo sapiens	Activity	%	100.79
	22844708	CHEMBL4721383	Inhibition of wild-type human partial length FES (I527 to R822 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	43.21	CHEMBL5455	Homo sapiens	Activity	%	43.21
	22886566	CHEMBL4728269	Binding affinity to FES (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	Delta Tm	degrees C	4.0	CHEMBL5455	Homo sapiens	deltaTm	degrees C	4.0
	22952837	CHEMBL4766774	Inhibition of recombinant human FES (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	22.0	CHEMBL5455	Homo sapiens	Activity	%	22.0
	23122570	CHEMBL4804921	Inhibition of human FES assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	81.0	CHEMBL5455	Homo sapiens	Activity	%	81.0
	23123265	CHEMBL4805509	Inhibition of human FES assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	23123626	CHEMBL4805870	Inhibition of DNA-tagged human FES assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	95.0	CHEMBL5455	Homo sapiens	Activity	%	95.0
	23124620	CHEMBL4806526	Inhibition of human FES assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	23124621	CHEMBL4806526	Inhibition of human FES assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5455	Homo sapiens	Activity	%	100.0
	23128101	CHEMBL4807842	Inhibition of FES (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5455	Homo sapiens	Activity	%	75.0
	23128102	CHEMBL4807842	Inhibition of FES (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5455	Homo sapiens	Activity	%	75.0
	23128103	CHEMBL4807842	Inhibition of FES (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5455	Homo sapiens	Activity	%	75.0
	23289192	CHEMBL4839030	Inhibition of Fes (unknown origin)	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	IC50	nM	4.9	CHEMBL5455	Homo sapiens	IC50	nM	4.9
	23289207	CHEMBL4839045	Inhibition of Fes (unknown origin) at 0.1 uM	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	Inhibition	%	95.0	CHEMBL5455	Homo sapiens	INH	%	95.0
Not Active	23317405	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	73.0	CHEMBL5455	Homo sapiens	% Control	%	73.0
Not Active	23317873	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	93.0	CHEMBL5455	Homo sapiens	% Control	%	93.0
Not Active	23318542	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23319023	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23319660	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23320135	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23320813	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23321281	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	98.0	CHEMBL5455	Homo sapiens	% Control	%	98.0
Not Active	23321911	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	96.0	CHEMBL5455	Homo sapiens	% Control	%	96.0
Not Active	23322379	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL5455	Homo sapiens	% Control	%	97.0
Not Active	23323068	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	93.0	CHEMBL5455	Homo sapiens	% Control	%	93.0
Not Active	23323536	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	97.0	CHEMBL5455	Homo sapiens	% Control	%	97.0
Not Active	23324008	CHEMBL4880627	Fes (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-36.0	CHEMBL5455	Homo sapiens	% inhibition	%	-36.0
Not Active	23324390	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23325025	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23325493	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23326140	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	92.0	CHEMBL5455	Homo sapiens	% Control	%	92.0
Not Active	23326608	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	64.0	CHEMBL5455	Homo sapiens	% Control	%	64.0
Not Active	23327308	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23327776	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	93.0	CHEMBL5455	Homo sapiens	% Control	%	93.0
Not Active	23328363	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	83.0	CHEMBL5455	Homo sapiens	% Control	%	83.0
Not Active	23328831	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23329342	CHEMBL4881049	Fes(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	108.0	CHEMBL5455	Homo sapiens	% residual kinase activity	%	108.0
Not Active	23329777	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23330245	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	96.0	CHEMBL5455	Homo sapiens	% Control	%	96.0
Not Active	23331001	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23331469	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23332056	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	84.6	CHEMBL5455	Homo sapiens	% Control	%	84.6
Not Active	23332522	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23333240	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	84.1	CHEMBL5455	Homo sapiens	% Control	%	84.1
Not Active	23333879	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23334347	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23334893	CHEMBL4881517	Fes (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	28.0	CHEMBL5455	Homo sapiens	% inhibition	%	28.0
Not Active	23335326	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23335794	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23336421	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	95.0	CHEMBL5455	Homo sapiens	% Control	%	95.0
Not Active	23336889	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	99.0	CHEMBL5455	Homo sapiens	% Control	%	99.0
Not Active	23337593	CHEMBL4881964	FES Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	94.5	CHEMBL5455	Homo sapiens	% Ctrl	%	94.5
Not Active	23337970	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23338438	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23339050	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23339518	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23340155	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23340623	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23341280	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	96.0	CHEMBL5455	Homo sapiens	% Control	%	96.0
Not Active	23341748	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23342364	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	73.0	CHEMBL5455	Homo sapiens	% Control	%	73.0
Not Active	23342832	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	96.0	CHEMBL5455	Homo sapiens	% Control	%	96.0
Not Active	23343462	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	94.0	CHEMBL5455	Homo sapiens	% Control	%	94.0
Not Active	23343930	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL5455	Homo sapiens	% Control	%	95.0
Not Active	23344568	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	82.0	CHEMBL5455	Homo sapiens	% Control	%	82.0
Not Active	23345141	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23345609	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23346186	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23346655	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23347260	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23347746	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23348325	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23348793	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	87.0	CHEMBL5455	Homo sapiens	% Control	%	87.0
Not Active	23349380	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	88.0	CHEMBL5455	Homo sapiens	% Control	%	88.0
Not Active	23349998	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23350466	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23351071	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	79.0	CHEMBL5455	Homo sapiens	% Control	%	79.0
Not Active	23351539	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	92.0	CHEMBL5455	Homo sapiens	% Control	%	92.0
Not Active	23352044	CHEMBL4882735	FES (FPS) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	6.034	CHEMBL5455	Homo sapiens	% Inhibition	%	6.0339
Not Active	23352563	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	87.0	CHEMBL5455	Homo sapiens	% Control	%	87.0
Not Active	23353031	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	93.0	CHEMBL5455	Homo sapiens	% Control	%	93.0
Not Active	23353913	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23354381	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23355113	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23355581	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23356217	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23356685	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23357294	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23357941	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	76.0	CHEMBL5455	Homo sapiens	% Control	%	76.0
Not Active	23358409	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	91.0	CHEMBL5455	Homo sapiens	% Control	%	91.0
Not Active	23358995	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	94.5	CHEMBL5455	Homo sapiens	% Control	%	94.5
Not Active	23359593	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	53.0	CHEMBL5455	Homo sapiens	% Control	%	53.0
Not Active	23360061	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	77.0	CHEMBL5455	Homo sapiens	% Control	%	77.0
Not Active	23360646	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23361114	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23361687	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23362223	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23362691	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	99.0	CHEMBL5455	Homo sapiens	% Control	%	99.0
Not Active	23364333	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23364801	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23365540	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23366083	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	81.0	CHEMBL5455	Homo sapiens	% Control	%	81.0
Not Active	23366673	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23367141	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23367569	CHEMBL4883922	FES ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	121.0	CHEMBL5455	Homo sapiens	% Residual activity with Skepinone-L	%	121.0
Not Active	23368019	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23368487	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23369086	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	75.0	CHEMBL5455	Homo sapiens	% Control	%	75.0
Not Active	23369554	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23370064	CHEMBL4884308	Fes(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	89.0	CHEMBL5455	Homo sapiens	% residual kinase activity	%	89.0
Not Active	23370522	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	68.0	CHEMBL5455	Homo sapiens	% Control	%	68.0
Not Active	23370990	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	84.0	CHEMBL5455	Homo sapiens	% Control	%	84.0
Not Active	23371799	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23372267	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	87.0	CHEMBL5455	Homo sapiens	% Control	%	87.0
	23372744	CHEMBL4884709	Fes(FES1LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5455	Homo sapiens	pIC50		6.0
	23373153	CHEMBL4885000	Fes(FES1LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5455	Homo sapiens	pIC50		6.0
	23373514	CHEMBL4885291	Fes(FES1LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5455	Homo sapiens	pIC50		6.0
Not Active	23374980	CHEMBL4885974	Fes Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	19.0	CHEMBL5455	Homo sapiens	% Inhibition	%	19.0
Not Active	23375247	CHEMBL4886229	feline sarcoma oncogene  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	13.0	CHEMBL5455	Homo sapiens	% inhibition	%	13.0
Not Active	23375694	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23376162	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23376739	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23377208	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	94.0	CHEMBL5455	Homo sapiens	% Control	%	94.0
Not Active	23378067	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	94.0	CHEMBL5455	Homo sapiens	% Control	%	94.0
Not Active	23378535	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	85.0	CHEMBL5455	Homo sapiens	% Control	%	85.0
Not Active	23379702	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	99.0	CHEMBL5455	Homo sapiens	% Control	%	99.0
Not Active	23380170	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	99.0	CHEMBL5455	Homo sapiens	% Control	%	99.0
Not Active	23380864	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23381512	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23381980	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23382604	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	82.0	CHEMBL5455	Homo sapiens	% Control	%	82.0
Not Active	23383072	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	74.0	CHEMBL5455	Homo sapiens	% Control	%	74.0
Not Active	23383788	CHEMBL4887426	FES Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	91.0	CHEMBL5455	Homo sapiens	% Ctrl	%	91.0
Not Active	23384273	CHEMBL4887868	Fes(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-11.86	CHEMBL5455	Homo sapiens	% inhibition	%	-11.86
Not Active	23384987	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
Not Active	23385454	CHEMBL4879711	KinomeScan assay: inhibition of FES	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5455	Homo sapiens	% Control	%	100.0
